disease,drug,phase,status,target,num_ev_strings
non-small cell lung carcinoma,ERLOTINIB,2,Completed,EGFR,75
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD4,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD3,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE3,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,PRIM1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,PRIM2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLA2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,RRM1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLA1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE2,73
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4B,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB6,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB8,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB3,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4A,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2A,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB1,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2B,70
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB8,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB2B,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB1,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB3,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB6,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB4B,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB4A,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB2A,69
non-small cell lung carcinoma,PEMETREXED,2,Completed,DHFR,66
non-small cell lung carcinoma,PEMETREXED,2,Completed,TYMS,66
non-small cell lung carcinoma,PEMETREXED,2,Completed,GART,66
non-small cell lung carcinoma,BEVACIZUMAB,2,Completed,VEGFA,44
lung carcinoma,PACLITAXEL,2,Completed,TUBB6,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB8,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB3,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB4B,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB4A,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB2B,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB1,43
lung carcinoma,PACLITAXEL,2,Completed,TUBB2A,43
lung carcinoma,GEMCITABINE,2,Completed,POLD1,39
lung carcinoma,GEMCITABINE,2,Completed,POLA1,39
lung carcinoma,GEMCITABINE,2,Completed,POLA2,39
lung carcinoma,GEMCITABINE,2,Completed,PRIM1,39
lung carcinoma,GEMCITABINE,2,Completed,POLD2,39
lung carcinoma,GEMCITABINE,2,Completed,POLD4,39
lung carcinoma,GEMCITABINE,2,Completed,RRM1,39
lung carcinoma,GEMCITABINE,2,Completed,PRIM2,39
lung carcinoma,GEMCITABINE,2,Completed,POLE2,39
lung carcinoma,GEMCITABINE,2,Completed,POLE,39
lung carcinoma,GEMCITABINE,2,Completed,POLE3,39
lung carcinoma,GEMCITABINE,2,Completed,POLD3,39
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,EGFR,38
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB8,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB1,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2A,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB6,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4B,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4A,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB3,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2B,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB2B,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB1,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB2A,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB6,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB3,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB4A,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB4B,36
lung carcinoma,DOCETAXEL,2,Completed,TUBB8,36
non-small cell lung carcinoma,ERLOTINIB,3,Completed,EGFR,28
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,28
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB8,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB1,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB2A,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB2B,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB3,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB4A,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB4B,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB6,26
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",DHFR,25
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",GART,25
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",TYMS,25
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB3,25
lung carcinoma,PEMETREXED,2,Completed,DHFR,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,DHFR,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,GART,24
lung carcinoma,PEMETREXED,2,Completed,GART,24
non-small cell lung carcinoma,ERLOTINIB,2,Unknown status,EGFR,24
lung carcinoma,PEMETREXED,2,Completed,TYMS,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,DHFR,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,GART,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,TYMS,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,TYMS,24
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLA1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD4,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,DHFR,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,RRM1,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,TYMS,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,GART,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLA2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,PRIM2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,PRIM1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE3,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD3,23
non-small cell lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,23
lung carcinoma,ERLOTINIB,2,Completed,EGFR,23
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,EGFR,22
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB4A,22
non-small cell lung carcinoma,GEFITINIB,2,Completed,EGFR,22
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB6,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4B,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4A,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB8,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2B,21
lung carcinoma,BEVACIZUMAB,2,Completed,VEGFA,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB3,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB1,21
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB6,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2A,21
non-small cell lung carcinoma,ERLOTINIB,1,Completed,EGFR,21
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB2A,21
non-small cell lung carcinoma,CETUXIMAB,2,Completed,EGFR,21
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB,21
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB1,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4A,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB3,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2B,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2A,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,DHFR,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB6,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB8,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4B,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB6,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB8,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB8,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB6,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB4B,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB4A,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB3,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB2B,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB2A,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB1,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB2,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB3,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB4,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,19
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB2B,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,GART,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB3,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,19
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,GART,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB1,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,19
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,DHFR,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,TYMS,19
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB8,19
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,TYMS,19
lung carcinoma,PACLITAXEL,3,Completed,TUBB2B,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB2A,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB1,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB,18
non-small cell lung carcinoma,ERLOTINIB,2,Terminated,EGFR,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB3,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB4A,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB6,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB8,18
non-small cell lung carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,18
non-small cell lung carcinoma,PEMETREXED,1,Completed,GART,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB4B,18
non-small cell lung carcinoma,PEMETREXED,1,Completed,TYMS,17
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB1,16
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB4B,16
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE2,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB2A,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA2,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD3,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD4,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB4A,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB2B,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB3,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB4B,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB6,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB8,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE3,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,RRM1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM2,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD2,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB1,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB6,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB1,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2A,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2B,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB3,15
non-small cell lung carcinoma,GEFITINIB,2,Unknown status,EGFR,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4A,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4B,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB8,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB,15
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD1,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA2,14
non-small cell lung carcinoma,ERLOTINIB,1,Terminated,EGFR,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD3,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA1,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD4,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE3,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM1,14
lung carcinoma,ETOPOSIDE,2,Completed,TOP2A,14
lung carcinoma,ETOPOSIDE,2,Completed,TOP2B,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM2,14
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Recruiting,CD274,14
non-small cell lung carcinoma,BEVACIZUMAB,3,Completed,VEGFA,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",RRM1,14
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4A,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB1,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2A,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2B,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB6,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB6,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB8,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB8,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD1,13
lung carcinoma,PACLITAXEL,1,Completed,TUBB6,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,13
non-small cell lung carcinoma,GEFITINIB,3,Completed,EGFR,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA1,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA2,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD2,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD3,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB1,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD4,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE2,13
non-small cell lung carcinoma,PEMETREXED,1,Completed,DHFR,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE3,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM1,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM2,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,RRM1,13
lung carcinoma,PACLITAXEL,1,Completed,TUBB3,13
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB8,12
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB8,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB6,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4B,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4A,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB3,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2B,12
non-small cell lung carcinoma,DURVALUMAB,2,Recruiting,CD274,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,12
lung carcinoma,TOPOTECAN,2,Completed,TOP1MT,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB1,12
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2A,12
small cell lung carcinoma,TOPOTECAN,2,Completed,TOP1MT,12
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB3,12
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4B,12
lung carcinoma,PACLITAXEL,1,Completed,TUBB8,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB8,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB4B,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB4A,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB3,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB1,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB6,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB2A,11
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,GART,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB2B,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB1,11
lung carcinoma,ETOPOSIDE,3,Completed,TOP2A,11
lung carcinoma,ETOPOSIDE,3,Completed,TOP2B,11
lung carcinoma,GEFITINIB,2,Completed,EGFR,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB8,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB6,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB4B,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB4A,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB3,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB2A,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB1,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB8,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB6,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB4A,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB3,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB2B,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB2A,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB1,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB4B,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB2B,11
non-small cell lung carcinoma,NIVOLUMAB,2,"Active, not recruiting",PDCD1,11
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",EGFR,11
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB2B,11
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB1,11
lung carcinoma,VINORELBINE,2,Completed,TUBB3,10
lung carcinoma,VINORELBINE,2,Completed,TUBB1,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB8,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB6,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB4B,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB4A,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB2B,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB2A,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB1,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB,10
lung carcinoma,PACLITAXEL,1,Completed,TUBB2B,10
lung carcinoma,PACLITAXEL,1,Completed,TUBB2A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB6,10
lung carcinoma,VINORELBINE,2,Completed,TUBB8,10
lung carcinoma,VINORELBINE,2,Completed,TUBB6,10
lung carcinoma,VINORELBINE,2,Completed,TUBB4B,10
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",TYMS,10
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",GART,10
lung carcinoma,VINORELBINE,2,Completed,TUBB,10
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB4,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB8,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB3,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4B,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB1,10
lung carcinoma,VINORELBINE,2,Completed,TUBB2B,10
non-small cell lung carcinoma,ERLOTINIB,2,"Active, not recruiting",EGFR,10
lung carcinoma,VINORELBINE,2,Completed,TUBB2A,10
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB,10
small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2B,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,10
small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4A,10
lung carcinoma,VINORELBINE,2,Completed,TUBB4A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB3,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2B,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2A,10
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,RRM1,9
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4A,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB8,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB3,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,9
lung carcinoma,PEMETREXED,2,Terminated,TYMS,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLA1,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLD1,9
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4B,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLD2,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLD3,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLD4,9
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB2,9
lung carcinoma,PEMETREXED,2,Terminated,DHFR,9
lung carcinoma,PEMETREXED,2,Terminated,GART,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB2B,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB6,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,9
lung carcinoma,PACLITAXEL,1,Completed,TUBB4B,9
lung carcinoma,PACLITAXEL,1,Completed,TUBB4A,9
non-small cell lung carcinoma,NIVOLUMAB,3,Recruiting,PDCD1,9
lung carcinoma,PACLITAXEL,1,Completed,TUBB,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB3,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLE2,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB1,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLE,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLA2,9
lung carcinoma,GEMCITABINE,2,Unknown status,POLE3,9
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD2,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLA1,9
non-small cell lung carcinoma,AFATINIB,2,Completed,EGFR,9
non-small cell lung carcinoma,AFATINIB,2,Completed,ERBB2,9
non-small cell lung carcinoma,AFATINIB,2,Completed,ERBB4,9
lung carcinoma,GEMCITABINE,2,Unknown status,PRIM1,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB1,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB8,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB6,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD4,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLA2,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB2A,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB8,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB1,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB4A,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB4B,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB6,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB2B,9
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,PRIM2,9
lung carcinoma,GEMCITABINE,2,Unknown status,RRM1,9
lung carcinoma,GEMCITABINE,2,Unknown status,PRIM2,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,PRIM1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE2,9
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,8
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB3,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,8
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2A,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB6,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB8,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB1,8
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2B,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB1,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,8
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,TYMS,8
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB8,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB4,8
lung carcinoma,CETUXIMAB,2,Completed,EGFR,8
lung carcinoma,PACLITAXEL,1,Completed,TUBB1,8
non-small cell lung carcinoma,BEVACIZUMAB,1,Completed,VEGFA,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB8,8
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,DHFR,8
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,GART,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB6,8
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",DHFR,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB2,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,EGFR,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4B,8
non-small cell lung carcinoma,APATINIB,2,Recruiting,KDR,8
non-small cell lung carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2A,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2B,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB3,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB3,8
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4A,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,8
lung carcinoma,GEMCITABINE,3,Completed,POLD4,8
lung carcinoma,VINORELBINE,3,Completed,TUBB6,8
lung carcinoma,GEMCITABINE,3,Completed,POLD3,8
lung carcinoma,VINORELBINE,3,Completed,TUBB,8
lung carcinoma,GEMCITABINE,3,Completed,POLE,8
lung carcinoma,GEMCITABINE,3,Completed,POLE2,8
lung carcinoma,GEMCITABINE,3,Completed,POLE3,8
lung carcinoma,GEMCITABINE,3,Completed,PRIM1,8
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB6,8
lung carcinoma,GEMCITABINE,3,Completed,PRIM2,8
non-small cell lung carcinoma,NIVOLUMAB,1,Recruiting,PDCD1,8
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB2A,8
lung carcinoma,VINORELBINE,3,Completed,TUBB1,8
lung carcinoma,VINORELBINE,3,Completed,TUBB2A,8
lung carcinoma,GEMCITABINE,3,Completed,RRM1,8
small cell lung carcinoma,BEVACIZUMAB,2,Completed,VEGFA,8
lung carcinoma,VINORELBINE,3,Completed,TUBB4B,8
lung carcinoma,VINORELBINE,3,Completed,TUBB4A,8
lung carcinoma,VINORELBINE,3,Completed,TUBB3,8
lung carcinoma,GEMCITABINE,3,Completed,POLD2,8
lung carcinoma,VINORELBINE,3,Completed,TUBB2B,8
lung carcinoma,VINORELBINE,3,Completed,TUBB8,8
lung carcinoma,GEMCITABINE,3,Completed,POLA2,8
small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2B,8
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,8
small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2A,8
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2B,8
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",EGFR,8
lung carcinoma,GEMCITABINE,3,Completed,POLA1,8
lung carcinoma,GEMCITABINE,3,Completed,POLD1,8
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",EGFR,8
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,EGFR,8
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,8
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2A,8
lung carcinoma,GEMCITABINE,3,Unknown status,POLD1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA2,7
non-small cell lung carcinoma,PEMBROLIZUMAB,3,"Active, not recruiting",PDCD1,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLD2,7
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,DHFR,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLA2,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLA1,7
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD1,7
lung carcinoma,CELECOXIB,2,Completed,PTGS2,7
non-small cell lung carcinoma,DURVALUMAB,2,Not yet recruiting,CD274,7
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB4,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLD3,7
non-small cell lung carcinoma,ERLOTINIB,3,Terminated,EGFR,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLE,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA6,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,BRAF,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA7,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA8,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB2,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB6,7
lung carcinoma,GEMCITABINE,3,Unknown status,RRM1,7
lung carcinoma,GEMCITABINE,3,Unknown status,PRIM2,7
lung carcinoma,GEMCITABINE,3,Unknown status,PRIM1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB2,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB4,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLE3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,FLT1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,FLT4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,KDR,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,PTK6,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,RET,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,SRC,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,TEK,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLE2,7
small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2B,7
lung carcinoma,GEMCITABINE,3,Unknown status,POLD4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA5,7
small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2A,7
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE2,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB4B,7
non-small cell lung carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EGFR,7
non-small cell lung carcinoma,BORTEZOMIB,2,Completed,PSMB5,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,RAF1,7
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB6,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,RET,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB8,7
lung carcinoma,DOCETAXEL,1,Completed,TUBB2A,7
lung carcinoma,FILGRASTIM,2,Completed,CSF3R,7
non-small cell lung carcinoma,BEVACIZUMAB,3,Recruiting,VEGFA,7
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2A,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB6,7
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB,7
lung carcinoma,ETOPOSIDE,1,Completed,TOP2A,7
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4A,7
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB6,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA10,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,KIT,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,PDGFRB,7
non-small cell lung carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,7
non-small cell lung carcinoma,ERLOTINIB,4,Completed,EGFR,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB4A,7
non-small cell lung carcinoma,IPILIMUMAB,3,Recruiting,CTLA4,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT1,7
non-small cell lung carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT3,7
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB4A,7
non-small cell lung carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT4,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB3,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB2B,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB2A,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB1,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB,7
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,KDR,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA1,7
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,6
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB8,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB1,6
non-small cell lung carcinoma,PEMETREXED,1,Terminated,TYMS,6
small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2B,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2B,6
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,6
small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2B,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB8,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB6,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4B,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4A,6
small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2A,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB3,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB2B,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2A,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB2A,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB1,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB,6
lung carcinoma,ERLOTINIB,1,Completed,EGFR,6
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2B,6
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB,6
small cell lung carcinoma,IRINOTECAN,2,Completed,TOP1,6
non-small cell lung carcinoma,ERLOTINIB,3,"Active, not recruiting",EGFR,6
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB1,6
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB4B,6
non-small cell lung carcinoma,NIVOLUMAB,3,"Active, not recruiting",PDCD1,6
lung carcinoma,GEMCITABINE,1,Completed,POLD2,6
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB3,6
small cell lung carcinoma,ETOPOSIDE,3,"Active, not recruiting",TOP2A,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB8,6
small cell lung carcinoma,ETOPOSIDE,3,"Active, not recruiting",TOP2B,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB6,6
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,TYMS,6
non-small cell lung carcinoma,PEMETREXED,1,Terminated,DHFR,6
non-small cell lung carcinoma,GEMCITABINE,1,Completed,PRIM2,6
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB4B,6
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE,6
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD4,6
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLA1,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4B,6
non-small cell lung carcinoma,DURVALUMAB,3,"Active, not recruiting",CD274,6
non-small cell lung carcinoma,DURVALUMAB,3,Recruiting,CD274,6
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB8,6
non-small cell lung carcinoma,GEFITINIB,3,Recruiting,EGFR,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4A,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR3,6
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB2A,6
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB1,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,TYMS,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,GART,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,DHFR,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,KDR,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR2,6
lung carcinoma,DOCETAXEL,1,Completed,TUBB3,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB1,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2A,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2B,6
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC6,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB3,6
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB6,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,CSF1R,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",EGFR,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB1,6
non-small cell lung carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLA1,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB2A,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB3,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB4A,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB4B,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB6,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB8,6
lung carcinoma,TOPOTECAN,1,Completed,TOP1MT,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLA2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD3,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD4,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,RRM1,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,PRIM2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,PRIM1,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE3,6
lung carcinoma,PEMETREXED,2,Recruiting,TYMS,6
lung carcinoma,PEMETREXED,2,Recruiting,DHFR,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB2B,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB3,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB8,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB4,6
non-small cell lung carcinoma,AFATINIB,3,Completed,EGFR,6
non-small cell lung carcinoma,AFATINIB,3,Completed,ERBB2,6
non-small cell lung carcinoma,AFATINIB,3,Completed,ERBB4,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD2,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT1,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT3,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT4,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,KDR,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB4A,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB4A,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,KIT,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRA,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRB,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,RET,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB2,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB6,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD1,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB4B,6
lung carcinoma,PEMETREXED,2,Recruiting,GART,6
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB8,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB6,5
non-small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2A,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2B,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB4B,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB4A,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4B,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4A,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB3,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2B,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2A,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB1,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,5
non-small cell lung carcinoma,GEFITINIB,3,"Active, not recruiting",EGFR,5
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC3,5
non-small cell lung carcinoma,TRAMETINIB,1,Recruiting,MAP2K2,5
lung carcinoma,DOCETAXEL,1,Completed,TUBB4A,5
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FLT1,5
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FLT4,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,DHFR,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,GART,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,TYMS,5
non-small cell lung carcinoma,IRINOTECAN,2,Completed,TOP1,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB1,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB2A,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB2B,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB3,5
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB3,5
non-small cell lung carcinoma,BORTEZOMIB,2,Terminated,PSMB5,5
lung carcinoma,ETOPOSIDE,1,Completed,TOP2B,5
lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2A,5
lung carcinoma,GEMCITABINE,2,Terminated,PRIM1,5
lung carcinoma,GEMCITABINE,2,Terminated,PRIM2,5
lung carcinoma,GEMCITABINE,2,Terminated,RRM1,5
lung carcinoma,GEMCITABINE,3,Terminated,POLA1,5
lung carcinoma,GEMCITABINE,3,Terminated,POLA2,5
lung carcinoma,GEMCITABINE,3,Terminated,POLD1,5
lung carcinoma,GEMCITABINE,3,Terminated,POLD2,5
lung carcinoma,GEMCITABINE,3,Terminated,POLD3,5
lung carcinoma,GEMCITABINE,3,Terminated,POLD4,5
lung carcinoma,GEMCITABINE,3,Terminated,POLE,5
lung carcinoma,GEMCITABINE,3,Terminated,POLE2,5
lung carcinoma,GEMCITABINE,3,Terminated,POLE3,5
lung carcinoma,GEMCITABINE,3,Terminated,PRIM1,5
lung carcinoma,GEMCITABINE,3,Terminated,PRIM2,5
lung carcinoma,GEMCITABINE,3,Terminated,RRM1,5
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB8,5
small cell lung carcinoma,ETOPOSIDE,1,"Active, not recruiting",TOP2A,5
lung carcinoma,GEMCITABINE,2,Terminated,POLE3,5
lung carcinoma,GEMCITABINE,2,Terminated,POLE2,5
lung carcinoma,GEMCITABINE,2,Terminated,POLE,5
lung carcinoma,GEMCITABINE,1,Completed,PRIM2,5
lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2B,5
non-small cell lung carcinoma,ENZASTAURIN,2,Completed,PRKCB,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB8,5
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB8,5
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB4A,5
lung carcinoma,GEMCITABINE,1,Completed,POLD4,5
lung carcinoma,GEMCITABINE,1,Completed,PRIM1,5
lung carcinoma,GEMCITABINE,1,Completed,RRM1,5
lung carcinoma,GEMCITABINE,2,Terminated,POLD4,5
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB2,5
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB6,5
lung carcinoma,GEMCITABINE,2,Terminated,POLA1,5
lung carcinoma,GEMCITABINE,2,Terminated,POLA2,5
lung carcinoma,GEMCITABINE,2,Terminated,POLD1,5
lung carcinoma,GEMCITABINE,2,Terminated,POLD2,5
lung carcinoma,GEMCITABINE,2,Terminated,POLD3,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB6,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB8,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE3,5
non-small cell lung carcinoma,GEMCITABINE,1,Completed,RRM1,5
non-small cell lung carcinoma,GEMCITABINE,1,Completed,PRIM1,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,PRIM1,5
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE3,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD1,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,5
non-small cell lung carcinoma,PEMBROLIZUMAB,3,Recruiting,PDCD1,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,5
small cell lung carcinoma,PEMETREXED,2,Terminated,TYMS,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,5
small cell lung carcinoma,PEMETREXED,2,Terminated,GART,5
non-small cell lung carcinoma,APATINIB,2,Not yet recruiting,KDR,5
small cell lung carcinoma,PEMETREXED,2,Terminated,DHFR,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM1,5
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD2,5
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Recruiting,CD274,5
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLA2,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,5
lung carcinoma,PACLITAXEL,1,Terminated,TUBB1,4
lung carcinoma,PACLITAXEL,1,Terminated,TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB3,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2B,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2A,4
small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KDR,4
small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,FLT4,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2A,4
small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,PDGFRB,4
small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KIT,4
lung carcinoma,PACLITAXEL,1,Terminated,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB8,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB1,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB8,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB1,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB3,4
lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4A,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB2A,4
non-small cell lung carcinoma,ERLOTINIB,3,Unknown status,EGFR,4
lung carcinoma,ERLOTINIB,2,Terminated,EGFR,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB4A,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB4B,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB3,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE2,4
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE,4
lung carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,4
non-small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2B,4
non-small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2A,4
non-small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2B,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB1,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA4A,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA3E,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB6,4
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE3,4
non-small cell lung carcinoma,ERLOTINIB,3,Recruiting,EGFR,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB4A,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB4B,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB6,4
lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB6,4
small cell lung carcinoma,AMRUBICIN,2,Completed,TOP2A,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB8,4
lung carcinoma,CELECOXIB,1,Completed,PTGS2,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB1,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB2A,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB2B,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB3,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB8,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB6,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2A,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB6,4
lung carcinoma,PACLITAXEL,1,Terminated,TUBB4B,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB2A,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB1,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB2A,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB2B,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB3,4
non-small cell lung carcinoma,DURVALUMAB,1,Recruiting,CD274,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB2B,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB4B,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB6,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB3,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB4A,4
small cell lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2A,4
small cell lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2B,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB8,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB4B,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB1,4
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB3,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,FLT4,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,KDR,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,KIT,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,PDGFRB,4
non-small cell lung carcinoma,CETUXIMAB,3,Completed,EGFR,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB8,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB,4
non-small cell lung carcinoma,NIVOLUMAB,2,Not yet recruiting,PDCD1,4
non-small cell lung carcinoma,CRIZOTINIB,1,Completed,ALK,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB6,4
lung carcinoma,GEMCITABINE,1,Terminated,PRIM2,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2B,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB3,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4B,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB6,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB8,4
lung carcinoma,SORAFENIB,2,Completed,PDGFRB,4
lung carcinoma,SORAFENIB,2,Completed,RAF1,4
lung carcinoma,SORAFENIB,2,Completed,RET,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4A,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4B,4
small cell lung carcinoma,TOPOTECAN,3,Completed,TOP1MT,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4A,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB3,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2A,4
non-small cell lung carcinoma,CERITINIB,1,Recruiting,ALK,4
lung carcinoma,GEMCITABINE,1,Completed,POLA1,4
lung carcinoma,GEMCITABINE,1,Terminated,POLA2,4
lung carcinoma,GEMCITABINE,1,Terminated,PRIM1,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB8,4
lung carcinoma,GEMCITABINE,1,Terminated,POLD4,4
non-small cell lung carcinoma,CERITINIB,2,Recruiting,ALK,4
lung carcinoma,SORAFENIB,2,Completed,BRAF,4
lung carcinoma,SORAFENIB,2,Completed,FLT1,4
lung carcinoma,SORAFENIB,2,Completed,FLT3,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB1,4
lung carcinoma,SORAFENIB,2,Completed,FLT4,4
lung carcinoma,GEMCITABINE,1,Completed,POLE2,4
lung carcinoma,SORAFENIB,2,Completed,KDR,4
lung carcinoma,SORAFENIB,2,Completed,KIT,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB,4
lung carcinoma,GEMCITABINE,1,Completed,POLD1,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4B,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4B,4
lung carcinoma,IMATINIB,2,Completed,PDGFRB,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB8,4
non-small cell lung carcinoma,PEMETREXED,1,Terminated,GART,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB6,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4A,4
lung carcinoma,DOCETAXEL,1,Terminated,TUBB6,4
lung carcinoma,DOCETAXEL,1,Terminated,TUBB4B,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB4,4
lung carcinoma,IRINOTECAN,2,Completed,TOP1,4
non-small cell lung carcinoma,SELUMETINIB,1,Completed,MAP2K1,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB3,4
small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2A,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB6,4
lung carcinoma,IMATINIB,2,Completed,KIT,4
non-small cell lung carcinoma,NERATINIB,2,Completed,EGFR,4
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB2,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRA,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB2,4
non-small cell lung carcinoma,NINTEDANIB,1,Completed,PDGFRA,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,LCK,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD3,4
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",RRM1,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB3,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRB,4
lung carcinoma,IMATINIB,2,Completed,ABL1,4
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR1,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB4,4
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB,4
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD3,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB3,4
non-small cell lung carcinoma,CAPMATINIB,2,Recruiting,MET,4
non-small cell lung carcinoma,GEFITINIB,1,Completed,EGFR,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB3,4
lung carcinoma,OSIMERTINIB,1,Recruiting,EGFR,4
lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",EGFR,4
lung carcinoma,OSIMERTINIB,2,Recruiting,EGFR,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,RRM1,4
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA1,4
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA2,4
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD1,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE3,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,PRIM1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,PRIM2,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB1,4
non-small cell lung carcinoma,SELUMETINIB,2,Completed,MAP2K2,4
non-small cell lung carcinoma,SELUMETINIB,2,Completed,MAP2K1,4
lung carcinoma,DOCETAXEL,1,Completed,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2A,4
non-small cell lung carcinoma,GEFITINIB,2,Recruiting,EGFR,4
non-small cell lung carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2B,4
lung carcinoma,DOCETAXEL,1,Completed,TUBB6,4
lung carcinoma,DOCETAXEL,1,Completed,TUBB2B,4
non-small cell lung carcinoma,CRIZOTINIB,3,"Active, not recruiting",MET,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2A,4
lung carcinoma,DOCETAXEL,1,Completed,TUBB1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD4,4
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE,4
non-small cell lung carcinoma,CRIZOTINIB,3,"Active, not recruiting",ALK,4
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC2,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,KIT,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLA2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE2,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA1C,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD1,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD3,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB3,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD4,4
non-small cell lung carcinoma,DEXAMETHASONE,2,Completed,NR3C1,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2A,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB1,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB6,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,DHFR,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,GART,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,TYMS,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4A,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2A,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE3,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,PRIM1,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,PRIM2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,RRM1,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FLT1,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR3,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR1,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,CSF1R,4
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB1,4
non-small cell lung carcinoma,CRIZOTINIB,2,"Active, not recruiting",MET,4
non-small cell lung carcinoma,CRIZOTINIB,2,"Active, not recruiting",ALK,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA1A,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLA1,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA1B,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4B,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBA3C,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,KDR,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,ITK,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB4,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB3,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD2,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FLT4,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB6,4
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB6,4
non-small cell lung carcinoma,EVEROLIMUS,1,Completed,FKBP1A,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB2,4
small cell lung carcinoma,IRINOTECAN,2,Recruiting,TOP1,4
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD3,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLA2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLA1,4
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLA2,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA5,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2A,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,PDGFRA,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,PTK6,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,KIT,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA6,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA8,3
non-small cell lung carcinoma,ALECTINIB,2,Recruiting,ALK,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,KDR,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA7,3
lung carcinoma,PEMETREXED,3,Terminated,GART,3
non-small cell lung carcinoma,CAPMATINIB,1,Recruiting,MET,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB1,3
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB2,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,RET,3
non-small cell lung carcinoma,ALECTINIB,2,Recruiting,RET,3
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB1,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KIT,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB4,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,FLT1,3
non-small cell lung carcinoma,CELECOXIB,2,Completed,PTGS2,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT1,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT3,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,PDGFRB,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KDR,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,FLT4,3
non-small cell lung carcinoma,CERITINIB,2,Completed,ALK,3
non-small cell lung carcinoma,TREMELIMUMAB,3,"Active, not recruiting",CTLA4,3
non-small cell lung carcinoma,CANAKINUMAB,3,Recruiting,IL1B,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,SRC,3
non-small cell lung carcinoma,DACOMITINIB,1,Completed,EGFR,3
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB2,3
non-small cell lung carcinoma,AFATINIB,1,Completed,ERBB4,3
non-small cell lung carcinoma,CETUXIMAB,1,Completed,EGFR,3
non-small cell lung carcinoma,CETUXIMAB,2,"Active, not recruiting",EGFR,3
non-small cell lung carcinoma,AFATINIB,1,Completed,EGFR,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,TEK,3
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2A,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB6,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB4,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB2,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,FLT4,3
lung carcinoma,PEMETREXED,3,Terminated,TYMS,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB3,3
lung carcinoma,PEMETREXED,3,Terminated,DHFR,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB2A,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB2B,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB3,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB4A,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB4B,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB6,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB8,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB1,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FYN,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,HCK,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,KIT,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB2B,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB1,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB3,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB4A,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB4B,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB6,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB8,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,LCK,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,LYN,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,PDGFRB,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,SRC,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,SRMS,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB3,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB2A,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2B,3
lung carcinoma,NIVOLUMAB,3,"Active, not recruiting",PDCD1,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,RET,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB2A,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB1,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB4B,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB6,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB8,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC3,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC6,3
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Not yet recruiting,CD274,3
non-small cell lung carcinoma,TRAMETINIB,1,Recruiting,MAP2K1,3
non-small cell lung carcinoma,BEVACIZUMAB,1,Terminated,VEGFA,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FRK,3
non-small cell lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K2,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC1,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC2,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC3,3
non-small cell lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K1,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC6,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,ABL1,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,BLK,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,EPHA2,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FGR,3
non-small cell lung carcinoma,BEVACIZUMAB,2,Not yet recruiting,VEGFA,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB4A,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,YES1,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB4B,3
non-small cell lung carcinoma,CIXUTUMUMAB,2,Completed,IGF1R,3
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Completed,CD274,3
lung carcinoma,PACLITAXEL,1,Terminated,TUBB8,3
non-small cell lung carcinoma,BRIGATINIB,2,Recruiting,ALK,3
non-small cell lung carcinoma,BRIGATINIB,2,Recruiting,EGFR,3
non-small cell lung carcinoma,APATINIB,2,Unknown status,KDR,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,KDR,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EGFR,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA10,3
lung carcinoma,PEMETREXED,1,Completed,GART,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA2,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB6,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA4,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB8,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB6,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4B,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4A,3
lung carcinoma,THALIDOMIDE,2,Completed,CRBN,3
lung carcinoma,THALIDOMIDE,2,Completed,CUL4A,3
lung carcinoma,THALIDOMIDE,2,Completed,DDB1,3
lung carcinoma,THALIDOMIDE,2,Completed,RBX1,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB3,3
lung carcinoma,PACLITAXEL,1,Terminated,TUBB4A,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB1,3
lung carcinoma,VINORELBINE,1,Completed,TUBB8,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB8,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2A,3
non-small cell lung carcinoma,CRIZOTINIB,2,Recruiting,MET,3
non-small cell lung carcinoma,CRIZOTINIB,2,Recruiting,ALK,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB2B,3
lung carcinoma,PACLITAXEL,1,Terminated,TUBB,3
non-small cell lung carcinoma,CRIZOTINIB,1,Completed,MET,3
lung carcinoma,VINORELBINE,1,Completed,TUBB,3
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB3,3
lung carcinoma,VINORELBINE,1,Completed,TUBB2A,3
lung carcinoma,VINORELBINE,1,Completed,TUBB2B,3
lung carcinoma,VINORELBINE,1,Completed,TUBB3,3
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,3
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2B,3
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4A,3
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB6,3
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB8,3
small cell lung carcinoma,APATINIB,2,Not yet recruiting,KDR,3
small cell lung carcinoma,APATINIB,2,Recruiting,KDR,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB4A,3
lung carcinoma,VINORELBINE,1,Completed,TUBB4A,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB2A,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB2B,3
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM2,3
small cell lung carcinoma,DURVALUMAB,2,Recruiting,CD274,3
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,PRIM2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB7,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB8,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD1,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLA2,3
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,DHFR,3
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,RRM1,3
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD2,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,3
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,GART,3
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE2,3
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD4,3
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD3,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB8,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB6,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB11,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLA1,3
small cell lung carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,3
lung carcinoma,BUDESONIDE,2,Completed,NR3C1,3
non-small cell lung carcinoma,PEMBROLIZUMAB,1,"Active, not recruiting",PDCD1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA8,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA9,3
non-small cell lung carcinoma,PEMBROLIZUMAB,3,Not yet recruiting,PDCD1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAB1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF2,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB10,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB9,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB3,3
non-small cell lung carcinoma,FIGITUMUMAB,1,Completed,IGF1R,3
lung carcinoma,DOCETAXEL,1,Terminated,TUBB4A,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV3,3
non-small cell lung carcinoma,GEFITINIB,1,Recruiting,EGFR,3
lung carcinoma,DOCETAXEL,1,Terminated,TUBB,3
lung carcinoma,DOCETAXEL,1,Terminated,TUBB1,3
non-small cell lung carcinoma,GEFITINIB,1,"Active, not recruiting",EGFR,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",DHFR,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",GART,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",TYMS,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,3
small cell lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,3
small cell lung carcinoma,NIVOLUMAB,1,"Active, not recruiting",PDCD1,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,DHFR,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,GART,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,TYMS,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,DHFR,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,GART,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV2,3
lung carcinoma,DOCETAXEL,1,Completed,TUBB,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV1,3
small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP1,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB1,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFC1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFC2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS3,3
non-small cell lung carcinoma,GEFITINIB,4,Completed,EGFR,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS5,3
small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS7,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS8,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLA2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD1,3
lung carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2A,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4B,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB6,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB8,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,RBX1,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,DDB1,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB1,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2B,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD2,3
small cell lung carcinoma,TOPOTECAN,3,"Active, not recruiting",TOP1MT,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB3,3
small cell lung carcinoma,TOPOTECAN,2,"Active, not recruiting",TOP1MT,3
small cell lung carcinoma,TOPOTECAN,1,Completed,TOP1MT,3
non-small cell lung carcinoma,IRINOTECAN,2,Unknown status,TOP1,3
non-small cell lung carcinoma,IPILIMUMAB,2,Completed,CTLA4,3
non-small cell lung carcinoma,IPILIMUMAB,1,Recruiting,CTLA4,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4A,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB3,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2B,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2A,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLD2,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLD3,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLD4,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLE,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLE2,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLE3,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,PRIM1,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,PRIM2,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,RRM1,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLD1,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLA2,3
lung adenocarcinoma,GEMCITABINE,2,Recruiting,POLA1,3
small cell lung carcinoma,ETOPOSIDE,2,"Active, not recruiting",TOP2A,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB1,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FGFR1,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FGFR3,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FLT4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA12,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA3,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,RRM1,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM1,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE3,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA4L2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA5,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA7,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD4,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA13,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA11,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4A,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA10,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,KDR,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4B,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB6,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB8,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,GPD2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND4,3
non-small cell lung carcinoma,PEGFILGRASTIM,2,Terminated,CSF3R,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND4L,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND5,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA1,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,TYMS,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB5,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,3
non-small cell lung carcinoma,DURVALUMAB,2,Withdrawn,CD274,3
lung carcinoma,ERLOTINIB,2,"Active, not recruiting",EGFR,3
lung carcinoma,FILGRASTIM,2,Unknown status,CSF3R,3
lung carcinoma,GEMCITABINE,1,Terminated,POLD2,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB,3
lung carcinoma,GEMCITABINE,1,Terminated,POLA1,3
lung carcinoma,GEMCITABINE,1,Completed,POLE3,3
lung carcinoma,GEMCITABINE,1,Completed,POLE,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,3
non-small cell lung carcinoma,NECITUMUMAB,1,"Active, not recruiting",EGFR,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,3
lung carcinoma,GEMCITABINE,1,Completed,POLD3,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,3
lung carcinoma,GEMCITABINE,1,Terminated,POLD3,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB1,3
non-small cell lung carcinoma,ERLOTINIB,2,Recruiting,EGFR,3
lung carcinoma,GEFITINIB,1,Completed,EGFR,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB4B,3
lung carcinoma,GEMCITABINE,1,Terminated,POLE3,3
lung carcinoma,GEMCITABINE,1,Terminated,RRM1,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB6,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB8,3
non-small cell lung carcinoma,NIVOLUMAB,2,Withdrawn,PDCD1,3
lung carcinoma,GEMCITABINE,1,Terminated,POLE2,3
non-small cell lung carcinoma,ERLOTINIB,1,Recruiting,EGFR,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB3,3
lung carcinoma,ETOPOSIDE,2,Terminated,TOP2B,3
lung carcinoma,ETOPOSIDE,2,Terminated,TOP2A,3
squamous cell lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB2B,3
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR4,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB2A,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB4A,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,TYMS,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB2B,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB1,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB,3
non-small cell lung carcinoma,ONARTUZUMAB,3,Completed,MET,3
small cell lung carcinoma,IRINOTECAN,2,Unknown status,TOP1,3
lung carcinoma,GEFITINIB,3,Completed,EGFR,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,GART,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB3,3
small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2B,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,DHFR,3
small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2A,3
non-small cell lung carcinoma,RAMUCIRUMAB,2,Completed,KDR,3
small cell lung carcinoma,ETOPOSIDE,2,"Active, not recruiting",TOP2B,3
non-small cell lung carcinoma,DURVALUMAB,2,"Active, not recruiting",CD274,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP1,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB2A,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP3,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB4A,3
lung carcinoma,GEFITINIB,3,Unknown status,EGFR,3
non-small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2A,3
lung carcinoma,GEMCITABINE,1,Completed,POLA2,3
non-small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2B,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP2,3
small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB8,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB4B,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB6,3
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CG,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP2,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R2,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT4,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT3,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R1,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CB,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,KIT,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,KDR,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CA,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP1,2
non-small cell lung carcinoma,MOMELOTINIB,1,Terminated,JAK1,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB8,2
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP2,2
non-small cell lung carcinoma,BMS-690514,2,Completed,EGFR,2
non-small cell lung carcinoma,BMS-690514,2,Completed,KDR,2
non-small cell lung carcinoma,BMS-690514,2,Completed,FLT4,2
non-small cell lung carcinoma,BMS-690514,2,Completed,FLT1,2
non-small cell lung carcinoma,BMS-690514,2,Completed,ERBB4,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR4,2
non-small cell lung carcinoma,BMS-690514,2,Completed,ERBB2,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR3,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,RBX1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR2,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB1,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRG,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRB,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRA,2
non-small cell lung carcinoma,BEVACIZUMAB,4,Completed,VEGFA,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB2A,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB2B,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,DDB1,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,CUL4A,2
non-small cell lung carcinoma,NIVOLUMAB,3,Withdrawn,PDCD1,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,PDGFRB,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB1,2
non-small cell lung carcinoma,NIVOLUMAB,1,Not yet recruiting,PDCD1,2
non-small cell lung carcinoma,NIVOLUMAB,1,"Active, not recruiting",PDCD1,2
non-small cell lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B2,2
non-small cell lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B1,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CD,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CB,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,PDGFRA,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,RET,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,CRBN,2
non-small cell lung carcinoma,NIRAPARIB,1,Recruiting,PARP1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,TARIQUIDAR,3,Terminated,ABCB1,2
non-small cell lung carcinoma,TEMSIROLIMUS,2,Completed,FKBP1A,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFC1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,KDR,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R1,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND6,2
non-small cell lung carcinoma,CAPECITABINE,2,Completed,TYMS,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND4L,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,GPD2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA10,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA11,2
non-small cell lung carcinoma,CABOZANTINIB,2,Recruiting,MET,2
non-small cell lung carcinoma,CABOZANTINIB,2,Recruiting,KDR,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA12,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA13,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND1,2
non-small cell lung carcinoma,SUNITINIB,1,Completed,KDR,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB9,2
non-small cell lung carcinoma,ONARTUZUMAB,2,Completed,MET,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,KIT,2
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT4,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,RAF1,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,RET,2
non-small cell lung carcinoma,SUNITINIB,1,Completed,CSF1R,2
non-small cell lung carcinoma,CC-223,1,Completed,MTOR,2
non-small cell lung carcinoma,OLMUTINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA3,2
non-small cell lung carcinoma,CABOZANTINIB,1,Completed,MET,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB11,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB3,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2B,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2A,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB1,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,CSF1R,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB2,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB7,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB10,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAB1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA9,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA7,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA4L2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA4,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4A,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4B,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB6,2
non-small cell lung carcinoma,BEVACIZUMAB,3,Not yet recruiting,VEGFA,2
non-small cell lung carcinoma,AVELUMAB,2,"Active, not recruiting",CD274,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB3,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",PDGFRB,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,FLT4,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB8,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR1,2
non-small cell lung carcinoma,TREMELIMUMAB,1,Recruiting,CTLA4,2
non-small cell lung carcinoma,TREMELIMUMAB,2,Completed,CTLA4,2
non-small cell lung carcinoma,ALECTINIB,3,"Active, not recruiting",RET,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",KDR,2
non-small cell lung carcinoma,ALECTINIB,1,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FLT4,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR4,2
non-small cell lung carcinoma,ALECTINIB,3,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR3,2
non-small cell lung carcinoma,NIMOTUZUMAB,2,Terminated,EGFR,2
non-small cell lung carcinoma,ALECTINIB,1,Recruiting,RET,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,KDR,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR3,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,KIT,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB8,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB6,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4B,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR4,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,KIT,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,FLT4,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,KDR,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FLT4,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA5,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA6,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,KIT,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,PDGFRB,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4A,2
non-small cell lung carcinoma,ALECTINIB,1,Recruiting,ALK,2
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB4,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB4A,2
non-small cell lung carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK4,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,KIT,2
non-small cell lung carcinoma,AFATINIB,1,Completed,ERBB2,2
non-small cell lung carcinoma,AFATINIB,1,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,RET,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EGFR,2
non-small cell lung carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA4,2
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB3,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,KDR,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA3,2
non-small cell lung carcinoma,ABEMACICLIB,1,"Active, not recruiting",CDK4,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,FLT4,2
non-small cell lung carcinoma,ABEMACICLIB,1,"Active, not recruiting",CDK6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,FLT4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,FLT1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB3,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,PDGFRA,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,PDGFRB,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,RET,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA7,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA6,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA3,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA2,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,EGFR,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,ERBB2,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,ERBB4,2
non-small cell lung carcinoma,NECITUMUMAB,2,Completed,EGFR,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA8,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB1,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB2,2
non-small cell lung carcinoma,AXITINIB,2,Completed,KDR,2
non-small cell lung carcinoma,AZACITIDINE,2,Terminated,DNMT3A,2
non-small cell lung carcinoma,AZACITIDINE,2,Terminated,DNMT1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS7,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS8,2
non-small cell lung carcinoma,AZACITIDINE,1,Completed,DNMT1,2
non-small cell lung carcinoma,TRAMETINIB,1,Terminated,MAP2K1,2
non-small cell lung carcinoma,AXITINIB,2,Completed,FLT4,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB4,2
non-small cell lung carcinoma,AXITINIB,2,Completed,FLT1,2
non-small cell lung carcinoma,AVELUMAB,3,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,FLT1,2
non-small cell lung carcinoma,AVELUMAB,1,Recruiting,CD274,2
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Recruiting,CD274,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV1,2
non-small cell lung carcinoma,AZD-1775,2,Terminated,WEE1,2
non-small cell lung carcinoma,TOPOTECAN,3,Completed,TOP1MT,2
non-small cell lung carcinoma,TIVANTINIB,2,Completed,MET,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC11,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC5,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC7,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC8,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC9,2
non-small cell lung carcinoma,BEVACIZUMAB,1,"Active, not recruiting",VEGFA,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS4,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB4B,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFC2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV3,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB6,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2B,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB2,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB3,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB3,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB4,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,KDR,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,PDGFRB,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB3,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2A,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB1,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR1,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2A,2
non-small cell lung carcinoma,ATEZOLIZUMAB,2,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,FLT1,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,PTK6,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB1,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,ERBB2,2
non-small cell lung carcinoma,APATINIB,1,Recruiting,KDR,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,RET,2
non-small cell lung carcinoma,APATINIB,3,Recruiting,KDR,2
non-small cell lung carcinoma,APATINIB,3,Unknown status,KDR,2
non-small cell lung carcinoma,APRICOXIB,2,Completed,PTGS2,2
non-small cell lung carcinoma,ASPIRIN,2,Not yet recruiting,PTGS1,2
non-small cell lung carcinoma,ASPIRIN,2,Not yet recruiting,PTGS2,2
non-small cell lung carcinoma,ATEZOLIZUMAB,1,"Active, not recruiting",CD274,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB8,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,KDR,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,SIROLIMUS,1,Recruiting,FKBP1A,2
non-small cell lung carcinoma,DASATINIB,1,Completed,KIT,2
non-small cell lung carcinoma,DASATINIB,1,Completed,HCK,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FYN,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FRK,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FGR,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",SRMS,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",SRC,2
non-small cell lung carcinoma,SIROLIMUS,1,Completed,FKBP1A,2
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,TYMS,2
non-small cell lung carcinoma,DASATINIB,1,Completed,PDGFRB,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",LCK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FRK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FGR,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",BLK,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB4,2
non-small cell lung carcinoma,GEFITINIB,4,Terminated,EGFR,2
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,DHFR,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB2,2
non-small cell lung carcinoma,DASATINIB,1,Completed,LYN,2
non-small cell lung carcinoma,DASATINIB,1,Completed,SRMS,2
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2B,2
non-small cell lung carcinoma,SELUMETINIB,1,Recruiting,MAP2K1,2
non-small cell lung carcinoma,DEXAMETHASONE,3,Completed,NR3C1,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,GART,2
non-small cell lung carcinoma,DECITABINE,1,Completed,DNMT3A,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,DHFR,2
non-small cell lung carcinoma,FIGITUMUMAB,3,Terminated,IGF1R,2
non-small cell lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K1,2
non-small cell lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K2,2
non-small cell lung carcinoma,SELUMETINIB,1,Completed,MAP2K2,2
non-small cell lung carcinoma,GEFITINIB,1,Unknown status,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Withdrawn,EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,Terminated,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Terminated,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Unknown status,EGFR,2
non-small cell lung carcinoma,SELUMETINIB,2,Recruiting,MAP2K1,2
non-small cell lung carcinoma,SELUMETINIB,2,Recruiting,MAP2K2,2
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD2,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,EGFR,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Not yet recruiting,PDCD1,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,RET,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,BRAF,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,PRIM2,2
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Not yet recruiting,PDCD1,2
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Terminated,PDCD1,2
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB4,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB2,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,KDR,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,RAF1,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,RET,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD1,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,RAF1,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD3,2
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB2,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,KIT,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,TYMS,2
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD4,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLE,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLA1,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT1,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT3,2
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT4,2
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB2,2
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD2,2
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB4,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,TYMS,2
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB3,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",BCR,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB4,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB3,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB2,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,EGFR,2
non-small cell lung carcinoma,PONATINIB,2,Terminated,BCR,2
non-small cell lung carcinoma,PONATINIB,2,Terminated,ABL1,2
non-small cell lung carcinoma,PONATINIB,2,Completed,BCR,2
non-small cell lung carcinoma,PONATINIB,2,Completed,ABL1,2
non-small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",ABL1,2
non-small cell lung carcinoma,PYROTINIB,2,Unknown status,ERBB2,2
non-small cell lung carcinoma,PONATINIB,1,Recruiting,BCR,2
non-small cell lung carcinoma,PONATINIB,1,Recruiting,ABL1,2
non-small cell lung carcinoma,DURVALUMAB,1,Not yet recruiting,CD274,2
non-small cell lung carcinoma,EGF816,1,Recruiting,EGFR,2
non-small cell lung carcinoma,ENOBOSARM,3,Completed,AR,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC10,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC11,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC2,2
non-small cell lung carcinoma,PYROTINIB,2,Unknown status,EGFR,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB8,2
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB8,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB1,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB2B,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB3,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB4B,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB6,2
non-small cell lung carcinoma,RAMUCIRUMAB,2,Not yet recruiting,KDR,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB6,2
non-small cell lung carcinoma,RAMUCIRUMAB,1,"Active, not recruiting",KDR,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB1,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2B,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB3,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4B,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC3,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC4,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC5,2
non-small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2A,2
non-small cell lung carcinoma,ERLOTINIB,1,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB4B,2
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2B,2
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB1,2
non-small cell lung carcinoma,ERLOTINIB,2,Withdrawn,EGFR,2
non-small cell lung carcinoma,ERLOTINIB,3,Withdrawn,EGFR,2
non-small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2B,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC7,2
non-small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2B,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB3,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4B,2
non-small cell lung carcinoma,PERTUZUMAB,2,Completed,ERBB2,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CA,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC8,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC9,2
non-small cell lung carcinoma,PIOGLITAZONE,2,Terminated,PPARG,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC1,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC11,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC2,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC3,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC4,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC5,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC6,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC7,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC8,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC9,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R5,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R3,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R1,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CG,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD3,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,2
non-small cell lung carcinoma,COBIMETINIB,1,Recruiting,MAP2K1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,FLT4,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,KDR,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,CSF1R,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT3,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,KDR,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,LINSITINIB,2,Completed,IGF1R,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,2
non-small cell lung carcinoma,LINSITINIB,2,Completed,INSR,2
non-small cell lung carcinoma,MAPATUMUMAB,2,Completed,TNFRSF10A,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,RET,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,RAF1,2
non-small cell lung carcinoma,CETUXIMAB,2,Terminated,EGFR,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,RET,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,BRAF,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,2
non-small cell lung carcinoma,CERITINIB,3,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,2
non-small cell lung carcinoma,CERITINIB,1,Completed,ALK,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,KDR,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,BRAF,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT1,2
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGAV,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT3,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT4,2
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGAV,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,KDR,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,KIT,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,FLT1,2
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,CRBN,2
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CCND1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,KDR,2
non-small cell lung carcinoma,CRIZOTINIB,2,Terminated,MET,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,RRM1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRB,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRA,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,LCK,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,KDR,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD2,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,ITK,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT4,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR3,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,CSF1R,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE3,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT3,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,RRM1,2
non-small cell lung carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD3,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD4,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE2,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,BRAF,2
non-small cell lung carcinoma,CRIZOTINIB,3,Recruiting,MET,2
non-small cell lung carcinoma,CRIZOTINIB,3,Recruiting,ALK,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD3,2
non-small cell lung carcinoma,PALBOCICLIB,1,Recruiting,CCND1,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB1,2
non-small cell lung carcinoma,IRINOTECAN,1,Terminated,TOP1,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB3,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,RAF1,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB4B,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB6,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB8,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB2A,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD4,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB2B,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB3,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB4A,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB4B,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB6,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB8,2
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CCND1,2
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CCND1,2
non-small cell lung carcinoma,IPILIMUMAB,1,Completed,CTLA4,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,CSF1R,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FLT1,2
non-small cell lung carcinoma,IMATINIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,RRM1,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,PDGFRA,2
non-small cell lung carcinoma,CRIZOTINIB,2,Terminated,ALK,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,LCK,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,KIT,2
non-small cell lung carcinoma,CRIZOTINIB,2,Not yet recruiting,MET,2
non-small cell lung carcinoma,CRIZOTINIB,2,Not yet recruiting,ALK,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,PDGFRB,2
non-small cell lung carcinoma,PAZOPANIB,1,Completed,ITK,2
non-small cell lung carcinoma,IMATINIB,2,Completed,ABL1,2
non-small cell lung carcinoma,IMATINIB,2,Completed,KIT,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC10,2
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,EGFR,2
small cell lung carcinoma,EVEROLIMUS,1,Completed,FKBP1A,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB3,2
lung carcinoma,SORAFENIB,1,Completed,FLT1,2
lung carcinoma,SORAFENIB,1,Completed,FLT3,2
lung carcinoma,SORAFENIB,1,Completed,KDR,2
lung carcinoma,SORAFENIB,1,Completed,KIT,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB3,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB4A,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB4B,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB6,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB8,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB1,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB2A,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB2B,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB4A,2
lung carcinoma,NIRAPARIB,2,Recruiting,PARP1,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB4B,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB6,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB8,2
lung carcinoma,ISOTRETINOIN,2,Completed,RARA,2
lung carcinoma,ISOTRETINOIN,2,Completed,RARB,2
lung carcinoma,ISOTRETINOIN,2,Completed,RARG,2
lung carcinoma,SORAFENIB,1,Completed,PDGFRB,2
lung carcinoma,SORAFENIB,1,Completed,RET,2
small cell lung carcinoma,ETOPOSIDE,1,Not yet recruiting,TOP2B,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB3,2
small cell lung carcinoma,ETOPOSIDE,1,"Active, not recruiting",TOP2B,2
lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,2
lung carcinoma,NIRAPARIB,2,Recruiting,PARP2,2
lung carcinoma,SORAFENIB,1,Completed,BRAF,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB2B,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB2A,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB1,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLE,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,2
small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,2
lung adenocarcinoma,BEVACIZUMAB,2,Terminated,VEGFA,2
small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB3,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB4A,2
lung carcinoma,SARGRAMOSTIM,1,Completed,CSF2RA,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP3,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP2,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP1,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP3,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP2,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP1,2
non-small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP2,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB4B,2
small cell lung carcinoma,ETOPOSIDE,3,Not yet recruiting,TOP2A,2
small cell lung carcinoma,ETOPOSIDE,3,Not yet recruiting,TOP2B,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB6,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB8,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB2B,2
lung carcinoma,GEMCITABINE,1,Terminated,POLE,2
lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,2
lung adenocarcinoma,PEMETREXED,2,Unknown status,TYMS,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,2
lung adenocarcinoma,PEMETREXED,2,Unknown status,DHFR,2
lung carcinoma,SS1(DSFV)-PE38,1,Completed,MSLN,2
lung carcinoma,SUNITINIB,2,Completed,CSF1R,2
lung adenocarcinoma,PEMETREXED,2,Unknown status,GART,2
lung carcinoma,SUNITINIB,2,Completed,FLT1,2
lung carcinoma,SUNITINIB,2,Completed,FLT3,2
lung carcinoma,SUNITINIB,2,Completed,FLT4,2
lung carcinoma,SUNITINIB,2,Completed,KDR,2
lung carcinoma,SUNITINIB,2,Completed,KIT,2
lung carcinoma,SUNITINIB,2,Completed,PDGFRA,2
squamous cell lung carcinoma,DURVALUMAB,2,Recruiting,CD274,2
lung carcinoma,SUNITINIB,2,Completed,PDGFRB,2
lung adenocarcinoma,PEMETREXED,4,Unknown status,DHFR,2
lung carcinoma,SUNITINIB,2,Completed,RET,2
lung adenocarcinoma,PEMETREXED,4,Unknown status,GART,2
lung carcinoma,GEFITINIB,2,Recruiting,EGFR,2
lung carcinoma,GEFITINIB,2,"Active, not recruiting",EGFR,2
small cell lung carcinoma,FILGRASTIM,2,Completed,CSF3R,2
lung adenocarcinoma,PEMETREXED,4,Unknown status,TYMS,2
lung adenocarcinoma,PONATINIB,2,"Active, not recruiting",ABL1,2
lung adenocarcinoma,PONATINIB,2,"Active, not recruiting",BCR,2
small cell lung carcinoma,SUNITINIB,2,Completed,CSF1R,2
small cell lung carcinoma,SUNITINIB,2,Completed,FLT1,2
small cell lung carcinoma,SUNITINIB,2,Completed,FLT3,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,2
lung carcinoma,SORAFENIB,2,Terminated,BRAF,2
lung carcinoma,SORAFENIB,2,Terminated,FLT1,2
lung carcinoma,SORAFENIB,2,Terminated,FLT3,2
lung carcinoma,SORAFENIB,2,Terminated,FLT4,2
lung carcinoma,SORAFENIB,2,Terminated,KDR,2
squamous cell lung carcinoma,ERLOTINIB,2,Completed,EGFR,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB1,2
lung carcinoma,GEFITINIB,2,Unknown status,EGFR,2
lung carcinoma,SORAFENIB,2,Terminated,KIT,2
lung carcinoma,SORAFENIB,2,Terminated,PDGFRB,2
lung carcinoma,SORAFENIB,2,Terminated,RAF1,2
lung carcinoma,SORAFENIB,2,Terminated,RET,2
lung adenocarcinoma,PEMETREXED,2,Completed,DHFR,2
lung adenocarcinoma,PEMETREXED,2,Completed,GART,2
lung adenocarcinoma,PEMETREXED,2,Completed,TYMS,2
lung adenocarcinoma,PEMETREXED,2,Not yet recruiting,DHFR,2
lung adenocarcinoma,PEMETREXED,2,Not yet recruiting,GART,2
lung adenocarcinoma,PEMETREXED,2,Not yet recruiting,TYMS,2
lung adenocarcinoma,PEMETREXED,2,Recruiting,DHFR,2
lung adenocarcinoma,PEMETREXED,2,Recruiting,GART,2
lung adenocarcinoma,OSIMERTINIB,2,Recruiting,EGFR,2
lung adenocarcinoma,NIVOLUMAB,2,Recruiting,PDCD1,2
lung adenocarcinoma,PEMETREXED,2,Recruiting,TYMS,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,2
squamous cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,2
lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,2
lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,2
lung carcinoma,MARIMASTAT,3,Completed,MMP1,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB6,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB2B,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB2A,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB8,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB1,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,2
lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM2,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB3,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB4A,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB1,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2A,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2B,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB3,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4A,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4B,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB6,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB6,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2A,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB1,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,2
lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB2,2
lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB3,2
lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB4,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB6,2
lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,VOLOCIXIMAB,1,Completed,ITGA5,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB4B,2
lung carcinoma,OSIMERTINIB,2,Not yet recruiting,EGFR,2
lung carcinoma,IMATINIB,1,Completed,ABL1,2
lung carcinoma,IMATINIB,1,Completed,KIT,2
lung carcinoma,OSIMERTINIB,3,Completed,EGFR,2
lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB4,2
lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB3,2
small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC1,2
small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC2,2
small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC3,2
lung carcinoma,PACLITAXEL,1,Terminated,TUBB3,2
small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC6,2
lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB2,2
lung adenocarcinoma,GEFITINIB,2,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC1,2
lung carcinoma,IMATINIB,1,Completed,PDGFRB,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB6,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB4A,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB3,2
lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLD4,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2A,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLD2,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLD1,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLA2,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLA1,2
lung carcinoma,GEMCITABINE,2,Withdrawn,RRM1,2
lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM2,2
lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM1,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLE3,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLE2,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLE,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLD3,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB2B,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLD2,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLD1,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC6,2
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC1,2
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB4B,2
lung carcinoma,IPILIMUMAB,3,Completed,CTLA4,2
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC2,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLA2,2
lung carcinoma,GEMCITABINE,2,Withdrawn,POLA1,2
lung carcinoma,IRINOTECAN,3,Completed,TOP1,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB1,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB2A,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB2B,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2B,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4A,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB2A,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB1,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB2A,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB2B,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB3,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB4A,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB4B,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB6,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB,2
lung carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,2
lung carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,2
lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM1,2
lung carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLE3,2
lung carcinoma,PEMETREXED,1,Completed,DHFR,2
lung adenocarcinoma,ERLOTINIB,2,Completed,EGFR,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLE2,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLE,2
lung adenocarcinoma,ERLOTINIB,1,Completed,EGFR,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLD4,2
lung carcinoma,PEMETREXED,1,Completed,TYMS,2
lung carcinoma,GEMCITABINE,3,Withdrawn,POLD3,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB6,2
small cell lung carcinoma,SUNITINIB,2,Completed,FLT4,2
lung carcinoma,GEMCITABINE,3,Withdrawn,RRM1,2
lung carcinoma,MARIMASTAT,3,Completed,MMP12,2
lung carcinoma,VANDETANIB,2,Terminated,FLT1,2
small cell lung carcinoma,TOPOTECAN,1,"Active, not recruiting",TOP1MT,2
lung carcinoma,BORTEZOMIB,2,Completed,PSMB5,2
lung carcinoma,VANDETANIB,2,Completed,EPHB3,2
small cell lung carcinoma,TOPOTECAN,1,Recruiting,TOP1MT,2
small cell lung carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,2
non-small cell lung carcinoma,ZOLEDRONIC ACID,3,Completed,FDPS,2
lung carcinoma,VANDETANIB,2,Completed,EPHB4,2
lung carcinoma,VANDETANIB,2,Completed,EPHB6,2
lung carcinoma,VANDETANIB,2,Completed,ERBB2,2
lung carcinoma,VANDETANIB,2,Completed,ERBB3,2
lung carcinoma,MARIMASTAT,3,Completed,MMP2,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB4A,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB2B,2
bronchoalveolar adenocarcinoma,ERLOTINIB,2,Completed,EGFR,2
lung carcinoma,VANDETANIB,2,Completed,ERBB4,2
lung carcinoma,VANDETANIB,2,Completed,FLT1,2
small cell lung carcinoma,TOPOTECAN,2,Terminated,TOP1MT,2
small cell lung carcinoma,TOPOTECAN,2,Unknown status,TOP1MT,2
lung carcinoma,CEDIRANIB,2,Completed,KIT,2
lung carcinoma,VANDETANIB,2,Completed,FLT4,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB1,2
small cell lung carcinoma,METHOTREXATE,3,"Active, not recruiting",DHFR,2
lung carcinoma,VANDETANIB,2,Terminated,TEK,2
lung carcinoma,CEDIRANIB,2,Completed,PDGFRA,2
lung carcinoma,VANDETANIB,2,Completed,EPHB2,2
lung carcinoma,VANDETANIB,2,Completed,EPHB1,2
lung carcinoma,VANDETANIB,2,Completed,EPHA1,2
small cell lung carcinoma,IRINOTECAN,3,Completed,TOP1,2
lung carcinoma,DOCETAXEL,1,Terminated,TUBB8,2
lung carcinoma,TIPIFARNIB,2,Completed,FNTA,2
lung carcinoma,TIPIFARNIB,2,Completed,FNTB,2
lung carcinoma,TOPOTECAN,3,Completed,TOP1MT,2
lung carcinoma,TRASTUZUMAB,2,Completed,ERBB2,2
lung carcinoma,TRETINOIN,2,Unknown status,RARA,2
lung carcinoma,TRETINOIN,2,Unknown status,RARB,2
lung carcinoma,TRETINOIN,2,Unknown status,RARG,2
lung carcinoma,VANDETANIB,2,Completed,EGFR,2
lung carcinoma,VANDETANIB,2,Completed,EPHA10,2
small cell lung carcinoma,PEMETREXED,1,Terminated,DHFR,2
lung carcinoma,VANDETANIB,2,Completed,EPHA2,2
lung carcinoma,VANDETANIB,2,Completed,EPHA3,2
lung carcinoma,VANDETANIB,2,Completed,EPHA4,2
squamous cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CCND1,2
lung carcinoma,VANDETANIB,2,Completed,EPHA5,2
lung carcinoma,VANDETANIB,2,Completed,EPHA6,2
lung carcinoma,VANDETANIB,2,Completed,EPHA7,2
lung carcinoma,VANDETANIB,2,Completed,EPHA8,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB8,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB4B,2
small cell lung carcinoma,TREMELIMUMAB,2,Recruiting,CTLA4,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB8,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB6,2
lung carcinoma,VANDETANIB,2,Terminated,EPHB1,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA10,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA2,2
small cell lung carcinoma,PAZOPANIB,2,Completed,ITK,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA3,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA4,2
small cell lung carcinoma,PAZOPANIB,2,Completed,FLT4,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA5,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA6,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA7,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA8,2
lung carcinoma,VANDETANIB,2,Terminated,EPHB2,2
small cell lung carcinoma,PAZOPANIB,2,Completed,KDR,2
lung carcinoma,VANDETANIB,2,Terminated,EPHB3,2
lung carcinoma,VANDETANIB,2,Terminated,EPHB4,2
lung carcinoma,VANDETANIB,2,Terminated,EPHB6,2
lung carcinoma,CEDIRANIB,2,Completed,FLT1,2
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB3,2
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2B,2
lung carcinoma,CEDIRANIB,2,Completed,FLT4,2
lung carcinoma,VANDETANIB,2,Terminated,ERBB2,2
lung carcinoma,VANDETANIB,2,Terminated,ERBB3,2
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,2
lung carcinoma,VANDETANIB,2,Terminated,EPHA1,2
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4B,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4B,2
lung carcinoma,CEDIRANIB,2,Completed,KDR,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4A,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB3,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2B,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2A,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB1,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,2
lung carcinoma,VANDETANIB,2,Terminated,SRC,2
lung carcinoma,VANDETANIB,2,Terminated,RET,2
small cell lung carcinoma,NIRAPARIB,1,Not yet recruiting,PARP2,2
lung carcinoma,VANDETANIB,2,Terminated,PTK6,2
lung carcinoma,VANDETANIB,2,Terminated,KDR,2
small cell lung carcinoma,PAZOPANIB,2,Completed,KIT,2
lung carcinoma,VANDETANIB,2,Completed,KDR,2
lung carcinoma,VANDETANIB,2,Completed,PTK6,2
lung carcinoma,VANDETANIB,2,Completed,RET,2
small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRB,2
lung carcinoma,VANDETANIB,2,Terminated,FLT4,2
small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRA,2
lung carcinoma,VANDETANIB,2,Completed,SRC,2
lung carcinoma,VANDETANIB,2,Completed,TEK,2
lung carcinoma,VANDETANIB,2,Terminated,EGFR,2
small cell lung carcinoma,PAZOPANIB,2,Completed,LCK,2
lung carcinoma,DOCETAXEL,1,Terminated,TUBB3,2
squamous cell lung carcinoma,PALBOCICLIB,2,Recruiting,CCND1,2
lung carcinoma,DOXORUBICIN,3,Completed,TOP2A,2
lung carcinoma,DOCETAXEL,1,Completed,TUBB8,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC6,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC5,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC4,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC3,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC2,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC11,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC10,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC1,2
small cell lung carcinoma,ANLOTINIB,2,Recruiting,FLT4,2
lung carcinoma,VINORELBINE,1,Completed,TUBB1,2
small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP2,2
small cell lung carcinoma,SUNITINIB,2,Completed,KDR,2
small cell lung carcinoma,SUNITINIB,2,Completed,KIT,2
lung carcinoma,ETOPOSIDE,1,Unknown status,TOP2A,2
small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRA,2
small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRB,2
lung carcinoma,DOCETAXEL,1,Terminated,TUBB2B,2
lung carcinoma,ERLOTINIB,3,Unknown status,EGFR,2
lung carcinoma,ERLOTINIB,3,Completed,EGFR,2
lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB4,2
lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB2,2
lung carcinoma,AFATINIB,2,"Active, not recruiting",EGFR,2
squamous cell lung carcinoma,TREMELIMUMAB,2,Recruiting,CTLA4,2
lung carcinoma,MARIMASTAT,3,Completed,MMP3,2
lung carcinoma,MARIMASTAT,3,Completed,MMP7,2
small cell lung carcinoma,ATEZOLIZUMAB,2,Recruiting,CD274,2
lung carcinoma,DACOMITINIB,3,Completed,ERBB4,2
lung carcinoma,DACOMITINIB,3,Completed,ERBB2,2
lung carcinoma,DACOMITINIB,3,Completed,EGFR,2
small cell lung carcinoma,ATEZOLIZUMAB,2,"Active, not recruiting",CD274,2
small cell lung carcinoma,ANLOTINIB,2,Recruiting,PDGFRB,2
small cell lung carcinoma,ANLOTINIB,2,Recruiting,KIT,2
large cell lung carcinoma,FIGITUMUMAB,3,Terminated,IGF1R,2
small cell lung carcinoma,ANLOTINIB,2,Recruiting,KDR,2
small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP3,2
small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP2,2
small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP1,2
lung carcinoma,MARIMASTAT,3,Completed,MMP9,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC9,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC8,2
small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC7,2
lung carcinoma,CELECOXIB,2,Unknown status,PTGS2,2
small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",BCR,2
lung carcinoma,ERLOTINIB,1,"Active, not recruiting",EGFR,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB8,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB4B,2
lung carcinoma,AMRUBICIN,3,Completed,TOP2A,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB4A,2
small cell lung carcinoma,IMATINIB,2,Completed,ABL1,2
small cell lung carcinoma,IMATINIB,2,Completed,KIT,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB3,2
lung carcinoma,EPACADOSTAT,2,"Active, not recruiting",IDO1,2
small cell lung carcinoma,IMATINIB,2,Completed,PDGFRB,2
lung carcinoma,ENZASTAURIN,2,Completed,PRKCB,2
small cell lung carcinoma,IPILIMUMAB,1,"Active, not recruiting",CTLA4,2
small cell lung carcinoma,IPILIMUMAB,1,Recruiting,CTLA4,2
small cell lung carcinoma,IPILIMUMAB,2,Completed,CTLA4,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB2B,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB2A,2
lung carcinoma,BEVACIZUMAB,1,Completed,VEGFA,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB1,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB,2
small cell lung carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,2
small cell lung carcinoma,PAZOPANIB,2,Completed,FLT1,2
small cell lung carcinoma,IRINOTECAN,2,"Active, not recruiting",TOP1,2
lung carcinoma,DOXORUBICIN,3,Unknown status,TOP2A,2
lung carcinoma,CEDIRANIB,2,Completed,PDGFRB,2
small cell lung carcinoma,OBATOCLAX,1,Completed,BCL2,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB6,2
lung carcinoma,VANDETANIB,2,Terminated,ERBB4,2
squamous cell lung carcinoma,PEMETREXED,2,Recruiting,DHFR,2
small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR1,2
small cell lung carcinoma,PAZOPANIB,2,Completed,CSF1R,2
small cell lung carcinoma,OBATOCLAX,1,Completed,MCL1,2
lung carcinoma,ERLOTINIB,1,Unknown status,EGFR,2
small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",ABL1,2
lung carcinoma,ERLOTINIB,2,Unknown status,EGFR,2
small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR3,2
small cell lung carcinoma,OBATOCLAX,1,Completed,BCL2L10,2
small cell lung carcinoma,SUNITINIB,2,Completed,RET,2
squamous cell lung carcinoma,PEMETREXED,2,Recruiting,TYMS,2
squamous cell lung carcinoma,PEMETREXED,2,Recruiting,GART,2
lung carcinoma,APATINIB,2,Not yet recruiting,KDR,2
lung carcinoma,APATINIB,2,Recruiting,KDR,2
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB8,1
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK4,1
non-small cell lung carcinoma,PACRITINIB,1,Terminated,JAK2,1
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB1,1
small cell lung carcinoma,TRETINOIN,2,Completed,RARG,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB2A,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB3,1
small cell lung carcinoma,UCN-01,1,Completed,CDK2,1
small cell lung carcinoma,UCN-01,1,Completed,CDK4,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB4A,1
small cell lung carcinoma,TRETINOIN,2,Completed,RARB,1
small cell lung carcinoma,TOPOTECAN,1,Terminated,TOP1MT,1
small cell lung carcinoma,TRETINOIN,2,Completed,RARA,1
small cell lung carcinoma,SORAFENIB,2,Completed,RAF1,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRA,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",LCK,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",ITK,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR3,1
small cell lung carcinoma,SORAFENIB,2,Completed,PDGFRB,1
small cell lung carcinoma,SORAFENIB,2,Completed,KIT,1
small cell lung carcinoma,SORAFENIB,2,Completed,KDR,1
small cell lung carcinoma,SORAFENIB,2,Completed,FLT4,1
small cell lung carcinoma,SORAFENIB,2,Completed,FLT3,1
small cell lung carcinoma,SORAFENIB,2,Completed,FLT1,1
small cell lung carcinoma,SORAFENIB,2,Completed,BRAF,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRB,1
small cell lung carcinoma,SORAFENIB,2,Completed,RET,1
small cell lung carcinoma,SIMVASTATIN,2,Recruiting,HMGCR,1
small cell lung carcinoma,SORAFENIB,2,Terminated,BRAF,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",PDGFRB,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",PDGFRA,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",KIT,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",FLT4,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",FLT3,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",FLT1,1
small cell lung carcinoma,SUNITINIB,1,"Active, not recruiting",CSF1R,1
small cell lung carcinoma,SORAFENIB,2,Terminated,RET,1
small cell lung carcinoma,SORAFENIB,2,Terminated,RAF1,1
small cell lung carcinoma,SORAFENIB,2,Terminated,PDGFRB,1
small cell lung carcinoma,SORAFENIB,2,Terminated,KIT,1
small cell lung carcinoma,SORAFENIB,2,Terminated,KDR,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB2B,1
small cell lung carcinoma,SORAFENIB,2,Terminated,FLT3,1
small cell lung carcinoma,SORAFENIB,2,Terminated,FLT1,1
small cell lung carcinoma,SIROLIMUS,1,Recruiting,FKBP1A,1
small cell lung carcinoma,SIMVASTATIN,2,Completed,HMGCR,1
non-small cell lung carcinoma,PALBOCICLIB,1,Recruiting,CDK4,1
small cell lung carcinoma,TAREXTUMAB,1,Completed,NOTCH3,1
non-small cell lung carcinoma,PANITUMUMAB,1,Completed,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,1,"Active, not recruiting",EGFR,1
small cell lung carcinoma,TEMSIROLIMUS,2,Completed,FKBP1A,1
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK6,1
small cell lung carcinoma,TIVANTINIB,2,Terminated,MET,1
small cell lung carcinoma,TOPOTECAN,2,Not yet recruiting,TOP1MT,1
small cell lung carcinoma,TOPOTECAN,2,Recruiting,TOP1MT,1
small cell lung carcinoma,TOPOTECAN,3,Terminated,TOP1MT,1
small cell lung carcinoma,TOPOTECAN,3,Unknown status,TOP1MT,1
small cell lung carcinoma,TREMELIMUMAB,1,Completed,CTLA4,1
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK4,1
small cell lung carcinoma,TREMELIMUMAB,3,"Active, not recruiting",CTLA4,1
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK4,1
small cell lung carcinoma,TREMELIMUMAB,3,Recruiting,CTLA4,1
non-small cell lung carcinoma,PANITUMUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,2,Suspended,EGFR,1
small cell lung carcinoma,SELINEXOR,2,Terminated,XPO1,1
non-small cell lung carcinoma,PANITUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR1,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",CSF1R,1
small cell lung carcinoma,TALADEGIB,1,Terminated,SMO,1
non-small cell lung carcinoma,PATRITUMAB,3,Terminated,ERBB3,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB8,1
small cell lung carcinoma,TALAZOPARIB,2,Recruiting,PARP1,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB6,1
non-small cell lung carcinoma,PARSATUZUMAB,2,Completed,EGFL7,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB4B,1
small cell lung carcinoma,TALAZOPARIB,2,Recruiting,PARP2,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB4A,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC7,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC3,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC2,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC10,1
small cell lung carcinoma,SORAFENIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA4,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB2A,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA3E,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1C,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1B,1
small cell lung carcinoma,PEMETREXED,3,Completed,TYMS,1
small cell lung carcinoma,PEMETREXED,3,Completed,GART,1
small cell lung carcinoma,PEMETREXED,3,Completed,DHFR,1
small cell lung carcinoma,PEMETREXED,2,Completed,TYMS,1
small cell lung carcinoma,PEMETREXED,2,Completed,GART,1
small cell lung carcinoma,PEMETREXED,2,Completed,DHFR,1
small cell lung carcinoma,PEMETREXED,1,Terminated,TYMS,1
small cell lung carcinoma,PEMETREXED,1,Terminated,GART,1
small cell lung carcinoma,PEMBROLIZUMAB,3,"Active, not recruiting",PDCD1,1
small cell lung carcinoma,PEMBROLIZUMAB,2,Withdrawn,PDCD1,1
small cell lung carcinoma,PEMBROLIZUMAB,2,Completed,PDCD1,1
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Completed,PDCD1,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA4A,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2A,1
small cell lung carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2B,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,RAF1,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,PDGFRB,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,MAPK11,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,KDR,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,FLT4,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,FLT1,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,FGFR1,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,BRAF,1
small cell lung carcinoma,PREXASERTIB,2,"Active, not recruiting",CHEK2,1
small cell lung carcinoma,PREXASERTIB,2,"Active, not recruiting",CHEK1,1
small cell lung carcinoma,POMALIDOMIDE,1,Terminated,RBX1,1
small cell lung carcinoma,POMALIDOMIDE,1,Terminated,CUL4A,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB8,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB4A,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB3,1
small cell lung carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRB,1
small cell lung carcinoma,REMINERTANT,2,Completed,NTSR1,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",ITK,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT1,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR3,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",FGFR1,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",CSF1R,1
small cell lung carcinoma,PASIREOTIDE,2,Unknown status,SSTR5,1
small cell lung carcinoma,PASIREOTIDE,2,Unknown status,SSTR3,1
small cell lung carcinoma,PASIREOTIDE,2,Unknown status,SSTR2,1
small cell lung carcinoma,PASIREOTIDE,2,Unknown status,SSTR1,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,DHFR,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,GART,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,TYMS,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB8,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB6,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",FLT4,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Withdrawn,PDCD1,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",KIT,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRA,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,LCK,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,KIT,1
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Unknown status,PDCD1,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,KDR,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,ITK,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT4,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT1,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR3,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR1,1
small cell lung carcinoma,PAZOPANIB,2,Terminated,CSF1R,1
non-small cell lung carcinoma,PEMBROLIZUMAB,4,Not yet recruiting,PDCD1,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRB,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",PDGFRA,1
small cell lung carcinoma,PAZOPANIB,2,"Active, not recruiting",LCK,1
small cell lung carcinoma,REGORAFENIB,1,Terminated,TEK,1
small cell lung carcinoma,RILOTUMUMAB,1,Completed,HGF,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB1,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB3,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB2A,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB1,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBA4A,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBA3E,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBA3C,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBA1C,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBA1B,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK9,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA3E,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK8,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK7,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK6,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK5,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,KIT,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB2B,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,ITK,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,PDGFRA,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FLT4,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA4A,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA3E,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA3C,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA1C,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA1B,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBA1A,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB8,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB6,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB4B,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB4A,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,CSF1R,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FGFR1,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FGFR3,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FLT1,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,LCK,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,PDGFRB,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK10,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK10,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK8,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK7,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK6,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK5,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK4,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK3,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK20,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK2,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK19,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK17,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK16,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK15,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK13,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK12,1
small cell lung carcinoma,RONICICLIB,1,Terminated,CDK11B,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK1,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK11B,1
non-small cell lung carcinoma,PD-0325901,1,"Active, not recruiting",MAP2K2,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK12,1
non-small cell lung carcinoma,PD-0325901,2,Terminated,MAP2K1,1
non-small cell lung carcinoma,PD-0325901,2,Terminated,MAP2K2,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK4,1
non-small cell lung carcinoma,PEGFILGRASTIM,4,Completed,CSF3R,1
non-small cell lung carcinoma,PELITINIB,2,Completed,EGFR,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK3,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK20,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK2,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK19,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK18,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK17,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK16,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK15,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK14,1
small cell lung carcinoma,RONICICLIB,2,Terminated,CDK13,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA4A,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB8,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA3C,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FLT4,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FLT1,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FGFR4,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FGFR3,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FGFR2,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,FGFR1,1
squamous cell lung carcinoma,NECITUMUMAB,2,Recruiting,EGFR,1
squamous cell lung carcinoma,MK-2206,2,Completed,AKT3,1
squamous cell lung carcinoma,MK-2206,2,Completed,AKT2,1
squamous cell lung carcinoma,MK-2206,2,Completed,AKT1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,1
squamous cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2A,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLD1,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLA1,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,1
squamous cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,1
squamous cell lung carcinoma,GEFITINIB,3,Completed,EGFR,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,RRM1,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM2,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM1,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE3,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE2,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD4,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD2,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD1,1
squamous cell lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLA1,1
squamous cell lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2B,1
squamous cell lung carcinoma,ETOPOSIDE,3,Unknown status,TOP2A,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLA2,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLD2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLD3,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,1
squamous cell lung carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,1
squamous cell lung carcinoma,IPILIMUMAB,3,Recruiting,CTLA4,1
squamous cell lung carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,1
squamous cell lung carcinoma,GLEMBATUMUMAB VEDOTIN,1,Terminated,GPNMB,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,RRM1,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,PRIM2,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,PRIM1,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLE3,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLE2,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLE,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLD4,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLD3,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLD2,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLD1,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLA2,1
squamous cell lung carcinoma,GEMCITABINE,4,Not yet recruiting,POLA1,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,RRM1,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,PRIM2,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,PRIM1,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLE3,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLE2,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLE,1
squamous cell lung carcinoma,GEMCITABINE,3,Completed,POLD4,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,KDR,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRA,1
squamous cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRB,1
squamous cell lung carcinoma,TALAZOPARIB,2,Recruiting,PARP2,1
squamous cell lung carcinoma,SIROLIMUS,1,Recruiting,FKBP1A,1
squamous cell lung carcinoma,SELINEXOR,1,Withdrawn,XPO1,1
squamous cell lung carcinoma,SAPANISERTIB,2,Recruiting,MTOR,1
squamous cell lung carcinoma,RILOTUMUMAB,2,Recruiting,HGF,1
squamous cell lung carcinoma,RILOTUMUMAB,2,"Active, not recruiting",HGF,1
squamous cell lung carcinoma,RIGOSERTIB,2,Completed,F2R,1
squamous cell lung carcinoma,PIOGLITAZONE,2,Recruiting,PPARG,1
squamous cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",TYMS,1
squamous cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",GART,1
squamous cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK6,1
squamous cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK4,1
squamous cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK6,1
squamous cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK4,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB2B,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4B,1
squamous cell lung carcinoma,TALAZOPARIB,2,Recruiting,PARP1,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3CA,1
squamous cell lung carcinoma,NIVOLUMAB,3,Recruiting,PDCD1,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3CB,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB4,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB6,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB4B,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB4A,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB3,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB2B,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB2A,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB1,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB,1
squamous cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP3,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3R5,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3R3,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3R2,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3R1,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3CG,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3CD,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3CB,1
squamous cell lung carcinoma,TASELISIB,2,Recruiting,PIK3CA,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3R5,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3R3,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3R2,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3R1,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3CG,1
squamous cell lung carcinoma,TASELISIB,2,"Active, not recruiting",PIK3CD,1
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2B,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB8,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB6,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4B,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4A,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB3,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2B,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2A,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB1,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,1
squamous cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2B,1
squamous cell lung carcinoma,ERLOTINIB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1C,1
small cell lung carcinoma,VANDETANIB,2,Completed,KDR,1
small cell lung carcinoma,VANDETANIB,2,Completed,FLT1,1
small cell lung carcinoma,VANDETANIB,2,Completed,ERBB4,1
small cell lung carcinoma,VANDETANIB,2,Completed,ERBB3,1
small cell lung carcinoma,VANDETANIB,2,Completed,ERBB2,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHB6,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHB4,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHB3,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHB2,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHB1,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA8,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA7,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA6,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA5,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA4,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA3,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA2,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA10,1
small cell lung carcinoma,VANDETANIB,2,Completed,EPHA1,1
small cell lung carcinoma,VANDETANIB,2,Completed,EGFR,1
small cell lung carcinoma,VALPROIC ACID,2,Completed,ALDH5A1,1
small cell lung carcinoma,UCN-01,2,Completed,PRKD3,1
small cell lung carcinoma,UCN-01,2,Completed,PRKD1,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCZ,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCQ,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCI,1
small cell lung carcinoma,VANDETANIB,2,Completed,FLT4,1
small cell lung carcinoma,VANDETANIB,2,Completed,PTK6,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB4B,1
small cell lung carcinoma,VANDETANIB,2,Completed,RET,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB4A,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3C,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1C,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1B,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1A,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB6,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB4B,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB4A,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB3,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB2B,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB2A,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB1,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB,1
small cell lung carcinoma,VELIPARIB,2,Completed,PARP3,1
small cell lung carcinoma,VELIPARIB,2,Completed,PARP2,1
small cell lung carcinoma,VELIPARIB,2,Completed,PARP1,1
small cell lung carcinoma,VELIPARIB,1,Recruiting,PARP2,1
small cell lung carcinoma,VELIPARIB,1,Recruiting,PARP1,1
small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP1,1
small cell lung carcinoma,VANDETANIB,2,Completed,TEK,1
small cell lung carcinoma,VANDETANIB,2,Completed,SRC,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCH,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB6,1
squamous cell lung carcinoma,ERLOTINIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB1,1
small cell lung carcinoma,UCN-01,1,Completed,PRKD3,1
small cell lung carcinoma,UCN-01,1,Completed,PRKD1,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCZ,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCQ,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCH,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCG,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCE,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCB,1
small cell lung carcinoma,UCN-01,1,Completed,PRKCA,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB8,1
small cell lung carcinoma,UCN-01,1,Completed,PDPK1,1
small cell lung carcinoma,UCN-01,1,Completed,CHEK1,1
small cell lung carcinoma,UCN-01,1,Completed,CDK6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA3C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1B,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCG,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1A,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB8,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCE,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCD,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCB,1
small cell lung carcinoma,UCN-01,2,Completed,PRKCA,1
small cell lung carcinoma,UCN-01,2,Completed,PDPK1,1
small cell lung carcinoma,UCN-01,2,Completed,CHEK1,1
small cell lung carcinoma,UCN-01,2,Completed,CDK6,1
small cell lung carcinoma,UCN-01,2,Completed,CDK4,1
small cell lung carcinoma,UCN-01,2,Completed,CDK2,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB3,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB1,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB1,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2A,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB1,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2A,1
squamous cell lung carcinoma,DURVALUMAB,2,"Active, not recruiting",CD274,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB3,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2A,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB1,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB3,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2A,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB1,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB8,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB6,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4B,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB3,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4A,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2B,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2A,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB1,1
small cell lung carcinoma,VISMODEGIB,2,Completed,SMO,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB8,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB6,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB3,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2B,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2A,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB8,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB6,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4B,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4A,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB3,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2B,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2A,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB1,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA4A,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB4B,1
small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2A,1
small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2B,1
squamous cell lung carcinoma,APATINIB,4,Not yet recruiting,KDR,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,EPHA2,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,YES1,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,SRMS,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,SRC,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,PDGFRB,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,LYN,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,LCK,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,KIT,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,HCK,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,FYN,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,FRK,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,FGR,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,BLK,1
squamous cell lung carcinoma,AZD-4547,1,Completed,FGFR1,1
squamous cell lung carcinoma,DASATINIB,2,Terminated,ABL1,1
squamous cell lung carcinoma,AZD-4547,2,Recruiting,FGFR4,1
squamous cell lung carcinoma,AZD-4547,2,Recruiting,FGFR3,1
squamous cell lung carcinoma,AZD-4547,2,Recruiting,FGFR2,1
squamous cell lung carcinoma,AZD-4547,2,Recruiting,FGFR1,1
squamous cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR4,1
squamous cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR3,1
squamous cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR2,1
squamous cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR1,1
squamous cell lung carcinoma,AZD-4547,1,Completed,FGFR4,1
squamous cell lung carcinoma,AZD-4547,1,Completed,FGFR3,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB3,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE5A,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,PDGFRA,1
non-small cell lung carcinoma,VEMURAFENIB,2,Recruiting,BRAF,1
non-small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP1,1
non-small cell lung carcinoma,VATALANIB,2,Completed,PDGFRB,1
non-small cell lung carcinoma,VATALANIB,2,Completed,PDGFRA,1
non-small cell lung carcinoma,VATALANIB,2,Completed,KIT,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,CSF1R,1
non-small cell lung carcinoma,VATALANIB,2,Completed,KDR,1
non-small cell lung carcinoma,VATALANIB,2,Completed,FLT4,1
non-small cell lung carcinoma,VATALANIB,2,Completed,FLT1,1
non-small cell lung carcinoma,VATALANIB,2,Completed,CSF1R,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT3,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,KDR,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,KIT,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,RET,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,CSF1R,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB1,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB2A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB1,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB8,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB6,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB3,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB1,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA4A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3E,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3C,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1C,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB8,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB6,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB4B,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB4A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB3,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB2B,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,RET,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB2,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA6,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA5,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,CRBN,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,CUL4A,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,DDB1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA10,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,RBX1,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE3A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE3B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4D,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,TEK,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB6,1
non-small cell lung carcinoma,SURAMIN,2,Completed,FGF1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",TEK,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",SRC,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,SURAMIN,2,Terminated,FGF1,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,RBX1,1
non-small cell lung carcinoma,SURAMIN,2,Unknown status,FGF1,1
non-small cell lung carcinoma,TALAZOPARIB,1,Withdrawn,PARP1,1
non-small cell lung carcinoma,TEMSIROLIMUS,1,Terminated,FKBP1A,1
non-small cell lung carcinoma,TEPOTINIB,1,"Active, not recruiting",MET,1
non-small cell lung carcinoma,TEPOTINIB,2,Recruiting,MET,1
non-small cell lung carcinoma,TEPROTUMUMAB,2,Completed,IGF1R,1
non-small cell lung carcinoma,TEPROTUMUMAB,2,Terminated,IGF1R,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,CRBN,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,CUL4A,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,DDB1,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB3,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,RET,1
non-small cell lung carcinoma,SELUMETINIB,2,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CD,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CA,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,MTOR,1
non-small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2B,1
non-small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2A,1
non-small cell lung carcinoma,SAVOLITINIB,1,Recruiting,MET,1
non-small cell lung carcinoma,SAVOLITINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK1,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK2,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK5,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK7,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK9,1
non-small cell lung carcinoma,SELINEXOR,1,Recruiting,XPO1,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC6,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC3,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC2,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC1,1
non-small cell lung carcinoma,SELUMETINIB,1,Not yet recruiting,MAP2K1,1
non-small cell lung carcinoma,SELUMETINIB,1,Not yet recruiting,MAP2K2,1
non-small cell lung carcinoma,SELUMETINIB,1,Recruiting,MAP2K2,1
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC1,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC6,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC2,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R1,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R5,1
non-small cell lung carcinoma,X-396,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB6,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA4A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT1,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB1,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR4,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB3,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB8,1
non-small cell lung carcinoma,X-396,2,Recruiting,ALK,1
non-small cell lung carcinoma,SAPANISERTIB,1,Recruiting,MTOR,1
non-small cell lung carcinoma,SARACATINIB,2,Completed,ABL1,1
non-small cell lung carcinoma,SARACATINIB,2,Completed,SRC,1
non-small cell lung carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR3,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR2,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR1,1
non-small cell lung carcinoma,XL-281,1,Completed,RAF1,1
non-small cell lung carcinoma,XL-281,1,Completed,BRAF,1
non-small cell lung carcinoma,X-396,3,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC1,1
non-small cell lung carcinoma,SELUMETINIB,2,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB4B,1
non-small cell lung carcinoma,SELUMETINIB,3,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB1,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB,1
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT3,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,BRAF,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,RAF1,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,RET,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB8,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB6,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4B,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4A,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB3,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2B,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB1,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB8,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2B,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB3,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,SELUMETINIB,3,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,SIBROTUZUMAB,1,Terminated,FAP,1
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC2,1
non-small cell lung carcinoma,SILDENAFIL,2,Completed,PDE5A,1
non-small cell lung carcinoma,SIMVASTATIN,1,"Active, not recruiting",HMGCR,1
non-small cell lung carcinoma,SIMVASTATIN,2,"Active, not recruiting",HMGCR,1
non-small cell lung carcinoma,VOLOCIXIMAB,1,Completed,ITGB1,1
non-small cell lung carcinoma,VOLASERTIB,2,Completed,PLK1,1
non-small cell lung carcinoma,SIROLIMUS,1,Withdrawn,FKBP1A,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",BRAF,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT3,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4A,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",RAF1,1
non-small cell lung carcinoma,VINTAFOLIDE,2,Completed,FOLR1,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB8,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB6,1
non-small cell lung carcinoma,SORAFENIB,1,Completed,BRAF,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4B,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,SRC,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE3A,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB1,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,PTK6,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB2,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA1,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB3,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,URELUMAB,1,Terminated,TNFRSF9,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKD3,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARG,1
non-small cell lung carcinoma,TREBANANIB,1,Completed,ANGPT1,1
non-small cell lung carcinoma,TREBANANIB,1,Completed,ANGPT2,1
non-small cell lung carcinoma,TREMELIMUMAB,1,"Active, not recruiting",CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,1,Completed,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Recruiting,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Withdrawn,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,3,Recruiting,CTLA4,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARA,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARB,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARA,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKD1,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARB,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARG,1
non-small cell lung carcinoma,UCN-01,1,Completed,CDK4,1
non-small cell lung carcinoma,UCN-01,1,Completed,CDK6,1
non-small cell lung carcinoma,UCN-01,1,Completed,CHEK1,1
non-small cell lung carcinoma,UCN-01,1,Completed,PDPK1,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCA,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCE,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCH,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCI,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,KDR,1
non-small cell lung carcinoma,VANDETANIB,1,Completed,SRC,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA1,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,TEK,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,RET,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,PTK6,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,KDR,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,FLT4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,ERBB3,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB2,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB1,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",TEK,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",SRC,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB6,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,KDR,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB3,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,SRC,1
non-small cell lung carcinoma,VANDETANIB,1,Terminated,TEK,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EGFR,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA10,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE3B,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB6,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,ANPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,AOPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,DNPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,LAP3,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,LNPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,METAP1D,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,METAP2,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,NPEPL1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,NPEPPS,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB2,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP3,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKA,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKB,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKC,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA6,1
non-small cell lung carcinoma,TOPOTECAN,2,Completed,TOP1MT,1
non-small cell lung carcinoma,TOPOTECAN,1,Recruiting,TOP1MT,1
non-small cell lung carcinoma,TOCILIZUMAB,1,Recruiting,IL6R,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB3,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4B,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,PTK6,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4C,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,FLT4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB4,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4D,1
non-small cell lung carcinoma,TIGATUZUMAB,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,TINZAPARIN SODIUM,3,Completed,SERPINC1,1
non-small cell lung carcinoma,TIPIFARNIB,2,Completed,FNTA,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,KDR,1
non-small cell lung carcinoma,TIPIFARNIB,2,Completed,FNTB,1
non-small cell lung carcinoma,TIPIFARNIB,2,Recruiting,FNTA,1
non-small cell lung carcinoma,TIPIFARNIB,2,Recruiting,FNTB,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB2,1
non-small cell lung carcinoma,TIVANTINIB,3,Completed,MET,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,FLT1,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,FLT4,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,KDR,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,FLT1,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,FLT4,1
non-small cell lung carcinoma,TRAMETINIB,1,Terminated,MAP2K2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA3,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB3,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB1,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB3,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB1,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA8,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB8,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA3,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,1,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,1,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA2,1
non-small cell lung carcinoma,TRAMETINIB,2,Completed,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,Completed,MAP2K2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA1,1
non-small cell lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,TRAMETINIB,2,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,TEK,1
non-small cell lung carcinoma,TRASTUZUMAB,1,Completed,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,SRC,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,RET,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,PTK6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Completed,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA3E,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA3C,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1C,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CD,1
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CD,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA1,1
small cell lung carcinoma,GEMCITABINE,1,Completed,PRIM2,1
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R2,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLE3,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLE2,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CA,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CB,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLE,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CD,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLD4,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLD3,1
small cell lung carcinoma,GEMCITABINE,1,Completed,POLA2,1
small cell lung carcinoma,GEFITINIB,2,Completed,EGFR,1
small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AB1,1
small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AA1,1
small cell lung carcinoma,GANETESPIB,1,Terminated,HSP90AB1,1
small cell lung carcinoma,GANETESPIB,1,Terminated,HSP90AA1,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CG,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R1,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R2,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R3,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R5,1
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CB,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA2,1
non-small cell lung carcinoma,PEVONEDISTAT,2,Recruiting,UBA3,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE3,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6C,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6D,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6G,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6H,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE7A,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,RRM1,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM2,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM1,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE2,1
non-small cell lung carcinoma,PEVONEDISTAT,2,Recruiting,NAE1,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD4,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD3,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD2,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE7B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE8A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE8B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE9A,1
small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD1,1
non-small cell lung carcinoma,PERTUZUMAB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CA,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CG,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4D,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3R3,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB2A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB2B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB3,1
small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB4A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB4B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB6,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB8,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1C,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA3C,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA4A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB1,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB2A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB2B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB3,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB4A,1
small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB4B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB6,1
small cell lung carcinoma,ETOPOSIDE,3,Withdrawn,TOP2A,1
small cell lung carcinoma,ETOPOSIDE,3,Withdrawn,TOP2B,1
small cell lung carcinoma,ETOPOSIDE,4,Unknown status,TOP2A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2A,1
non-small cell lung carcinoma,PIMASERTIB,1,Completed,MAP2K1,1
non-small cell lung carcinoma,PIMASERTIB,1,Completed,MAP2K2,1
non-small cell lung carcinoma,PIOGLITAZONE,2,Recruiting,PPARG,1
small cell lung carcinoma,FIGITUMUMAB,2,Terminated,IGF1R,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA3C,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB1,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2B,1
small cell lung carcinoma,ETOPOSIDE,4,Unknown status,TOP2B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB3,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB4B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB6,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB8,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB1,1
small cell lung carcinoma,EVEROLIMUS,3,"Active, not recruiting",FKBP1A,1
small cell lung carcinoma,EVEROLIMUS,2,Completed,FKBP1A,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA5,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA1,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1B,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,DHFR,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,BCL2A1,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,BCL2,1
small cell lung carcinoma,OBATOCLAX,1,Completed,BCL2L2-PABPN1,1
small cell lung carcinoma,OBATOCLAX,1,Completed,BCL2L1,1
small cell lung carcinoma,OBATOCLAX,1,Completed,BCL2A1,1
small cell lung carcinoma,NIVOLUMAB,2,"Active, not recruiting",PDCD1,1
small cell lung carcinoma,NIRAPARIB,1,Not yet recruiting,PARP3,1
small cell lung carcinoma,NIRAPARIB,1,Not yet recruiting,PARP1,1
small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRB,1
small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRA,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,DHFR,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,GART,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,TYMS,1
small cell lung carcinoma,NINTEDANIB,2,Completed,KDR,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FLT4,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FLT1,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR4,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR3,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR2,1
small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR1,1
small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2L1,1
small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2,1
small cell lung carcinoma,NAVITOCLAX,1,Completed,BCL2L2-PABPN1,1
non-small cell lung carcinoma,PEMETREXED,1,Withdrawn,GART,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,BCL2L1,1
non-small cell lung carcinoma,PEMETREXED,1,Withdrawn,DHFR,1
small cell lung carcinoma,OLAPARIB,2,Suspended,PARP3,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB8,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB6,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4B,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4A,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB3,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2B,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2A,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB1,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,1
small cell lung carcinoma,OLAPARIB,2,Suspended,PARP2,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,BCL2L10,1
small cell lung carcinoma,OLAPARIB,2,Suspended,PARP1,1
small cell lung carcinoma,OLAPARIB,2,Not yet recruiting,PARP3,1
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,GART,1
small cell lung carcinoma,OLAPARIB,2,Not yet recruiting,PARP2,1
small cell lung carcinoma,OLAPARIB,2,Not yet recruiting,PARP1,1
small cell lung carcinoma,OLAPARIB,1,"Active, not recruiting",PARP3,1
small cell lung carcinoma,OLAPARIB,1,"Active, not recruiting",PARP2,1
small cell lung carcinoma,OLAPARIB,1,"Active, not recruiting",PARP1,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,MCL1,1
small cell lung carcinoma,OBATOCLAX,3,Withdrawn,BCL2L2-PABPN1,1
small cell lung carcinoma,NAVITOCLAX,1,Completed,BCL2L1,1
small cell lung carcinoma,NAVITOCLAX,1,Completed,BCL2,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA2,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,GART,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,ADORA2B,1
small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Recruiting,TLR9,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE10A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1C,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE2A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE3A,1
small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Recruiting,TLR7,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,RRM1,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM2,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE3B,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM1,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE3,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE2,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4C,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD4,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD3,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD2,1
small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD1,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,ADORA2A,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,TYMS,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,GART,1
small cell lung carcinoma,LINSITINIB,2,Completed,INSR,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,TYMS,1
small cell lung carcinoma,LUCITANIB,2,Terminated,KDR,1
small cell lung carcinoma,LUCITANIB,2,Terminated,FLT4,1
small cell lung carcinoma,LUCITANIB,2,Terminated,FLT1,1
small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR2,1
small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR1,1
small cell lung carcinoma,LORVOTUZUMAB MERTANSINE,1,Terminated,NCAM1,1
small cell lung carcinoma,LITRONESIB,2,Completed,KIF11,1
small cell lung carcinoma,LITHIUM CARBONATE,1,Completed,GSK3B,1
small cell lung carcinoma,LITHIUM CARBONATE,1,Completed,GSK3A,1
small cell lung carcinoma,LINSITINIB,2,Completed,IGF1R,1
small cell lung carcinoma,IPILIMUMAB,3,Completed,CTLA4,1
small cell lung carcinoma,IRINOTECAN,4,Unknown status,TOP1,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,DHFR,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,GART,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,TYMS,1
small cell lung carcinoma,IRINOTECAN,3,Not yet recruiting,TOP1,1
small cell lung carcinoma,IRINOTECAN,2,Terminated,TOP1,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,DHFR,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,GART,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,TYMS,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,DHFR,1
small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB8,1
small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2A,1
small cell lung carcinoma,AMRUBICIN,3,Terminated,TOP2A,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK19,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK2,1
small cell lung carcinoma,BECATECARIN,2,Terminated,TOP1,1
small cell lung carcinoma,BB-10901,1,Completed,NCAM1,1
small cell lung carcinoma,AZD-6738,2,Recruiting,ATR,1
small cell lung carcinoma,AZD-6738,2,Not yet recruiting,ATR,1
small cell lung carcinoma,AZD-2014,2,Terminated,MTOR,1
small cell lung carcinoma,AZD-1775,2,Terminated,WEE1,1
small cell lung carcinoma,AZD-1775,2,"Active, not recruiting",WEE1,1
small cell lung carcinoma,AZD-1775,1,"Active, not recruiting",WEE1,1
small cell lung carcinoma,AVELUMAB,2,Recruiting,CD274,1
small cell lung carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,1
small cell lung carcinoma,ATEZOLIZUMAB,2,Not yet recruiting,CD274,1
small cell lung carcinoma,ATEZOLIZUMAB,1,Terminated,CD274,1
small cell lung carcinoma,APATINIB,3,Not yet recruiting,KDR,1
small cell lung carcinoma,APATINIB,2,Unknown status,KDR,1
small cell lung carcinoma,ANLOTINIB,2,"Active, not recruiting",PDGFRB,1
small cell lung carcinoma,ANLOTINIB,2,"Active, not recruiting",KIT,1
small cell lung carcinoma,ANLOTINIB,2,"Active, not recruiting",KDR,1
small cell lung carcinoma,ANLOTINIB,2,"Active, not recruiting",FLT4,1
small cell lung carcinoma,AMUVATINIB,2,Completed,PDGFRA,1
small cell lung carcinoma,AMUVATINIB,2,Completed,MET,1
small cell lung carcinoma,AMUVATINIB,2,Completed,KIT,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK18,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK17,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK16,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R1,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK11B,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4B,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4A,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB3,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2B,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2A,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB1,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R5,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R2,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CG,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK15,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CD,1
small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CA,1
small cell lung carcinoma,BMS-833923,1,Completed,SMO,1
small cell lung carcinoma,BI-2536,2,Completed,PLK1,1
small cell lung carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
small cell lung carcinoma,BECATECARIN,2,Terminated,TOP2B,1
small cell lung carcinoma,BECATECARIN,2,Terminated,TOP2A,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK12,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK13,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK14,1
small cell lung carcinoma,AMUVATINIB,2,Completed,FLT3,1
small cell lung carcinoma,AMRUBICIN,3,Completed,TOP2A,1
small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2B,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK20,1
non-small cell lung carcinoma,XL-999,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,RUCAPARIB,1,Recruiting,PARP1,1
non-small cell lung carcinoma,XL-999,2,Terminated,KIT,1
non-small cell lung carcinoma,RUCAPARIB,1,Recruiting,PARP2,1
non-small cell lung carcinoma,RUXOLITINIB,1,Unknown status,JAK1,1
non-small cell lung carcinoma,XL-999,2,Terminated,KDR,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT4,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT3,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT1,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR4,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR3,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR2,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR1,1
non-small cell lung carcinoma,XL-999,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,RUXOLITINIB,1,Unknown status,JAK2,1
non-small cell lung carcinoma,RUXOLITINIB,2,Terminated,JAK1,1
non-small cell lung carcinoma,RUXOLITINIB,2,Terminated,JAK2,1
non-small cell lung carcinoma,XL-999,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,XL-999,1,Terminated,KIT,1
non-small cell lung carcinoma,XL-999,1,Terminated,KDR,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT4,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1A,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT3,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK9,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK8,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK7,1
small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB4,1
small cell lung carcinoma,AMRUBICIN,2,Terminated,TOP2A,1
small cell lung carcinoma,ALISERTIB,2,Completed,AURKA,1
small cell lung carcinoma,ALDOXORUBICIN,2,Withdrawn,TOP2A,1
small cell lung carcinoma,ALDOXORUBICIN,2,Unknown status,TOP2A,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK4,1
small cell lung carcinoma,AFLIBERCEPT,2,Completed,VEGFA,1
small cell lung carcinoma,AFLIBERCEPT,2,Completed,PGF,1
small cell lung carcinoma,AFATINIB,2,Withdrawn,ERBB4,1
small cell lung carcinoma,AFATINIB,2,Withdrawn,ERBB2,1
small cell lung carcinoma,AFATINIB,2,Withdrawn,EGFR,1
small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB2,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK6,1
small cell lung carcinoma,AFATINIB,2,Recruiting,EGFR,1
small cell lung carcinoma,ACETAZOLAMIDE,1,Not yet recruiting,CA4,1
small cell lung carcinoma,ACETAZOLAMIDE,1,Not yet recruiting,CA2,1
pulmonary neuroendocrine tumor,EVEROLIMUS,1,Completed,FKBP1A,1
non-small cell lung carcinoma,ZOLEDRONIC ACID,2,Recruiting,FDPS,1
non-small cell lung carcinoma,ZOLEDRONIC ACID,2,Completed,FDPS,1
non-small cell lung carcinoma,ZIBOTENTAN,2,Completed,EDNRA,1
non-small cell lung carcinoma,ZALUTUMUMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,ZALUTUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,XL-999,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK10,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK1,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC9,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC8,1
small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2A,1
small cell lung carcinoma,ETOPOSIDE,2,Suspended,TOP2B,1
small cell lung carcinoma,ETOPOSIDE,2,Suspended,TOP2A,1
small cell lung carcinoma,ETOPOSIDE,1,Not yet recruiting,TOP2A,1
small cell lung carcinoma,EPACADOSTAT,2,Withdrawn,IDO1,1
small cell lung carcinoma,ENZASTAURIN,2,Completed,PRKCB,1
small cell lung carcinoma,ENOXAPARIN SODIUM,3,Completed,SERPINC1,1
small cell lung carcinoma,ENOXAPARIN SODIUM,2,Withdrawn,SERPINC1,1
small cell lung carcinoma,DURVALUMAB,3,Recruiting,CD274,1
small cell lung carcinoma,DURVALUMAB,3,"Active, not recruiting",CD274,1
small cell lung carcinoma,DURVALUMAB,1,Completed,CD274,1
small cell lung carcinoma,DOXORUBICIN,3,"Active, not recruiting",TOP2A,1
small cell lung carcinoma,DOXORUBICIN,2,Completed,TOP2A,1
small cell lung carcinoma,DOXORUBICIN,1,Terminated,TOP2A,1
non-small cell lung carcinoma,ROCILETINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,3,Terminated,EGFR,1
non-small cell lung carcinoma,ROFECOXIB,2,Completed,PTGS2,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC1,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC10,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC11,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC2,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC3,1
small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2B,1
non-small cell lung carcinoma,ROCILETINIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,ROCILETINIB,1,Terminated,EGFR,1
non-small cell lung carcinoma,RAMUCIRUMAB,2,"Active, not recruiting",KDR,1
small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2A,1
non-small cell lung carcinoma,PLX-8394,1,Terminated,BRAF,1
non-small cell lung carcinoma,PRALATREXATE,1,Withdrawn,DHFR,1
non-small cell lung carcinoma,PRALATREXATE,2,Completed,DHFR,1
non-small cell lung carcinoma,PREXASERTIB,1,Completed,CHEK1,1
non-small cell lung carcinoma,PREXASERTIB,1,Completed,CHEK2,1
non-small cell lung carcinoma,R428,1,Recruiting,AXL,1
non-small cell lung carcinoma,R428,1,Unknown status,AXL,1
non-small cell lung carcinoma,R428,2,Recruiting,AXL,1
non-small cell lung carcinoma,RABUSERTIB,2,Completed,CHEK1,1
non-small cell lung carcinoma,RAMUCIRUMAB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,ROCILETINIB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,RAMUCIRUMAB,3,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,RAMUCIRUMAB,3,Completed,KDR,1
non-small cell lung carcinoma,RAMUCIRUMAB,4,n/a,KDR,1
non-small cell lung carcinoma,RETASPIMYCIN,2,Completed,HSP90AA1,1
non-small cell lung carcinoma,RETASPIMYCIN,2,Completed,HSP90AB1,1
non-small cell lung carcinoma,RIBOCICLIB,1,Completed,CDK4,1
non-small cell lung carcinoma,RIBOCICLIB,1,Completed,CDK6,1
non-small cell lung carcinoma,RIBOCICLIB,1,Recruiting,CDK4,1
non-small cell lung carcinoma,RIBOCICLIB,1,Recruiting,CDK6,1
non-small cell lung carcinoma,RIDAFOROLIMUS,2,Terminated,MTOR,1
small cell lung carcinoma,DOXORUBICIN,1,"Active, not recruiting",TOP2A,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB8,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB6,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,PDGFRB,1
small cell lung carcinoma,DASATINIB,2,Completed,FYN,1
small cell lung carcinoma,DASATINIB,2,Completed,FRK,1
small cell lung carcinoma,DASATINIB,2,Completed,FGR,1
small cell lung carcinoma,DASATINIB,2,Completed,EPHA2,1
small cell lung carcinoma,DASATINIB,2,Completed,BLK,1
small cell lung carcinoma,DASATINIB,2,Completed,ABL1,1
small cell lung carcinoma,DARBEPOETIN ALFA,3,Completed,EPOR,1
small cell lung carcinoma,CIXUTUMUMAB,2,Completed,IGF1R,1
small cell lung carcinoma,CHIAURANIB,1,Recruiting,KDR,1
small cell lung carcinoma,CHIAURANIB,1,Recruiting,FLT1,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,PDGFRA,1
small cell lung carcinoma,DASATINIB,2,Completed,KIT,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,KIT,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,KDR,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,FLT4,1
small cell lung carcinoma,CEDIRANIB,2,Suspended,FLT1,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB8,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB6,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC4,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC5,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC6,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC7,1
small cell lung carcinoma,DASATINIB,2,Completed,HCK,1
small cell lung carcinoma,DASATINIB,2,Completed,LCK,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4B,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB3,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4A,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB3,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2B,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2A,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB1,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB8,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB6,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,1
small cell lung carcinoma,DASATINIB,2,Completed,LYN,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB1,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
small cell lung carcinoma,DEXAMETHASONE,3,Withdrawn,NR3C1,1
small cell lung carcinoma,DEXAMETHASONE,3,Recruiting,NR3C1,1
small cell lung carcinoma,DESIPRAMINE,2,Terminated,SLC6A2,1
small cell lung carcinoma,DASATINIB,2,Completed,YES1,1
small cell lung carcinoma,DASATINIB,2,Completed,SRMS,1
small cell lung carcinoma,DASATINIB,2,Completed,SRC,1
small cell lung carcinoma,DASATINIB,2,Completed,PDGFRB,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB2,1
Lung Sarcomatoid Carcinoma,SAVOLITINIB,2,Recruiting,MET,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB4,1
lung carcinoma,ETOPOSIDE PHOSPHATE,1,Withdrawn,TOP2A,1
lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2A,1
lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2B,1
lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2A,1
lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2B,1
lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2A,1
lung carcinoma,ETOPOSIDE,1,Unknown status,TOP2B,1
lung carcinoma,ETOPOSIDE,1,Terminated,TOP2B,1
lung carcinoma,ETOPOSIDE,1,Terminated,TOP2A,1
lung carcinoma,ETOPOSIDE,1,Recruiting,TOP2B,1
lung carcinoma,ETOPOSIDE,1,Recruiting,TOP2A,1
lung carcinoma,ERLOTINIB,2,Withdrawn,EGFR,1
lung carcinoma,ERLOTINIB,2,Not yet recruiting,EGFR,1
lung carcinoma,ERLOTINIB,1,Withdrawn,EGFR,1
lung carcinoma,ERGOCALCIFEROL,1,Completed,VDR,1
lung carcinoma,EPOETIN ALFA,3,Completed,EPOR,1
lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2B,1
lung carcinoma,ETOPOSIDE PHOSPHATE,3,Completed,TOP2A,1
lung carcinoma,KETAMINE,2,Completed,GRIN3B,1
lung carcinoma,ETOPOSIDE PHOSPHATE,3,Unknown status,TOP2A,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM2,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,PRIM1,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE3,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLE2,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD3,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLD1,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,POLA1,1
lung carcinoma,FILGRASTIM,3,Unknown status,CSF3R,1
lung carcinoma,FILGRASTIM,3,Terminated,CSF3R,1
lung carcinoma,FILGRASTIM,3,Completed,CSF3R,1
lung carcinoma,FILGRASTIM,2,Withdrawn,CSF3R,1
lung carcinoma,FILGRASTIM,1,Completed,CSF3R,1
lung carcinoma,FIGITUMUMAB,1,Terminated,IGF1R,1
lung carcinoma,EVEROLIMUS,2,"Active, not recruiting",FKBP1A,1
lung carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,1
lung carcinoma,EPACADOSTAT,3,Terminated,IDO1,1
lung carcinoma,ENZASTAURIN,2,Withdrawn,PRKCB,1
lung carcinoma,EGF816,2,Recruiting,EGFR,1
lung carcinoma,EFAPROXIRAL,3,Withdrawn,HBB,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4A,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB3,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2B,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2A,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB1,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB8,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB6,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4B,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4A,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB3,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2B,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2A,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB1,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4B,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB6,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB8,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB8,1
lung carcinoma,EFAPROXIRAL,3,Withdrawn,HBA2,1
lung carcinoma,EFAPROXIRAL,2,Completed,HBB,1
lung carcinoma,EFAPROXIRAL,2,Completed,HBA2,1
lung carcinoma,DURVALUMAB,2,"Active, not recruiting",CD274,1
lung carcinoma,DOXORUBICIN,2,Terminated,TOP2A,1
lung carcinoma,DOXORUBICIN,1,Completed,TOP2A,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB6,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4B,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4A,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB3,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2B,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2A,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB1,1
lung carcinoma,FLUDARABINE PHOSPHATE,1,Recruiting,RRM1,1
lung carcinoma,FORETINIB,1,Completed,FLT1,1
lung carcinoma,FORETINIB,1,Completed,FLT3,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
lung carcinoma,IRINOTECAN,2,Withdrawn,TOP1,1
lung carcinoma,IRINOTECAN,2,Terminated,TOP1,1
lung carcinoma,IRINOTECAN,1,Completed,TOP1,1
lung carcinoma,IPILIMUMAB,4,Recruiting,CTLA4,1
lung carcinoma,IPILIMUMAB,3,"Active, not recruiting",CTLA4,1
lung carcinoma,IPILIMUMAB,2,Terminated,CTLA4,1
lung carcinoma,IMATINIB,2,Terminated,PDGFRB,1
lung carcinoma,IMATINIB,2,Terminated,KIT,1
lung carcinoma,IMATINIB,2,Terminated,ABL1,1
lung carcinoma,ILOPROST,2,Completed,PTGIR,1
lung carcinoma,IBRUTINIB,1,"Active, not recruiting",BTK,1
lung carcinoma,IBANDRONIC ACID,4,Terminated,FDPS,1
lung carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR9,1
lung carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR7,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,1
lung carcinoma,ISOTRETINOIN,3,Withdrawn,RARA,1
lung carcinoma,ISOTRETINOIN,3,Withdrawn,RARB,1
lung carcinoma,ISOTRETINOIN,3,Withdrawn,RARG,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB6,1
lung carcinoma,KETAMINE,2,Completed,GRIN2D,1
lung carcinoma,KETAMINE,2,Completed,GRIN2C,1
lung carcinoma,KETAMINE,2,Completed,GRIN2B,1
lung carcinoma,KETAMINE,2,Completed,GRIN2A,1
lung carcinoma,KETAMINE,2,Completed,GRIN1,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB8,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB4B,1
lung carcinoma,ITACITINIB,1,Recruiting,JAK1,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB4A,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB3,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB2B,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB2A,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB1,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,1
lung carcinoma,FORETINIB,1,Completed,FLT4,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,1
lung carcinoma,GEFITINIB,2,Terminated,EGFR,1
lung carcinoma,GEFITINIB,1,Unknown status,EGFR,1
lung carcinoma,FULVESTRANT,2,Completed,ESR2,1
lung carcinoma,FULVESTRANT,2,Completed,ESR1,1
lung carcinoma,FULVESTRANT,2,"Active, not recruiting",ESR2,1
lung carcinoma,FULVESTRANT,2,"Active, not recruiting",ESR1,1
lung carcinoma,FRUQUINTINIB,2,Recruiting,KDR,1
lung carcinoma,FRUQUINTINIB,2,Recruiting,FLT4,1
lung carcinoma,FRUQUINTINIB,2,Recruiting,FLT1,1
lung carcinoma,FORMOTEROL,1,Completed,ADRB2,1
lung carcinoma,FORETINIB,1,Completed,TEK,1
lung carcinoma,FORETINIB,1,Completed,PDGFRB,1
lung carcinoma,FORETINIB,1,Completed,PDGFRA,1
lung carcinoma,FORETINIB,1,Completed,MET,1
lung carcinoma,FORETINIB,1,Completed,KIT,1
lung carcinoma,GEFITINIB,3,Recruiting,EGFR,1
lung carcinoma,GEFITINIB,3,Terminated,EGFR,1
lung carcinoma,GEMCITABINE,1,Terminated,POLD1,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,1
lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,1
lung carcinoma,GEMCITABINE,1,Unknown status,RRM1,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLA2,1
lung carcinoma,GEMCITABINE,1,Unknown status,PRIM1,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLE3,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLE2,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLD3,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLD2,1
lung carcinoma,GEMCITABINE,1,Unknown status,POLD1,1
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB8,1
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB6,1
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4A,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3CA,1
lung carcinoma,CAROTUXIMAB,1,"Active, not recruiting",ENG,1
lung carcinoma,CAPMATINIB,2,Recruiting,MET,1
lung carcinoma,CAPECITABINE,2,Unknown status,TYMS,1
lung carcinoma,CANERTINIB,2,Completed,ERBB4,1
lung carcinoma,CANERTINIB,2,Completed,ERBB2,1
lung carcinoma,CANERTINIB,2,Completed,EGFR,1
lung carcinoma,BUPROPION,3,Terminated,SLC6A3,1
lung carcinoma,BUPROPION,3,Terminated,SLC6A2,1
lung carcinoma,BUPIVACAINE,4,Recruiting,SCN4A,1
lung carcinoma,BUPIVACAINE,2,Unknown status,SCN4A,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3R5,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3R3,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3R2,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3R1,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3CD,1
lung carcinoma,CEDIRANIB,1,Completed,FLT1,1
lung carcinoma,CEDIRANIB,1,Completed,KDR,1
lung carcinoma,CEDIRANIB,1,Completed,PDGFRA,1
lung carcinoma,CELECOXIB,3,Terminated,PTGS2,1
lung carcinoma,CETUXIMAB,3,"Active, not recruiting",EGFR,1
lung carcinoma,CETUXIMAB,2,Withdrawn,EGFR,1
lung carcinoma,CETUXIMAB,2,Terminated,EGFR,1
lung carcinoma,CETUXIMAB,2,"Active, not recruiting",EGFR,1
lung carcinoma,CETUXIMAB,1,Terminated,EGFR,1
lung carcinoma,CETUXIMAB,1,Completed,EGFR,1
lung carcinoma,CELECOXIB,2,Terminated,PTGS2,1
lung carcinoma,CEDIRANIB,1,Completed,PDGFRB,1
lung carcinoma,CEDIRANIB,3,Completed,PDGFRB,1
lung carcinoma,CEDIRANIB,3,Completed,PDGFRA,1
lung carcinoma,CEDIRANIB,3,Completed,KIT,1
lung carcinoma,CEDIRANIB,3,Completed,KDR,1
lung carcinoma,CEDIRANIB,3,Completed,FLT4,1
lung carcinoma,CEDIRANIB,3,Completed,FLT1,1
lung carcinoma,BUPARLISIB,1,Completed,PIK3CB,1
lung carcinoma,BUDESONIDE,4,Completed,NR3C1,1
lung carcinoma,CI-1040,2,Completed,MAP2K2,1
lung carcinoma,BUDESONIDE,1,Completed,NR3C1,1
lung carcinoma,BECATECARIN,2,Completed,TOP2B,1
lung carcinoma,BECATECARIN,2,Completed,TOP2A,1
lung carcinoma,BECATECARIN,2,Completed,TOP1,1
lung carcinoma,AZD-1775,2,Recruiting,WEE1,1
lung carcinoma,ANLOTINIB,2,Not yet recruiting,PDGFRB,1
lung carcinoma,ANLOTINIB,2,Not yet recruiting,KIT,1
lung carcinoma,ANLOTINIB,2,Not yet recruiting,KDR,1
lung carcinoma,ANLOTINIB,2,Not yet recruiting,FLT4,1
lung carcinoma,ANETUMAB RAVTANSINE,2,Terminated,MSLN,1
lung carcinoma,AMRUBICIN,3,"Active, not recruiting",TOP2A,1
lung carcinoma,AMRUBICIN,1,Completed,TOP2A,1
lung carcinoma,ALFENTANIL,4,Completed,OPRM1,1
lung carcinoma,ALECTINIB,2,Not yet recruiting,RET,1
lung carcinoma,ALECTINIB,2,Not yet recruiting,ALK,1
lung carcinoma,ALDESLEUKIN,2,Unknown status,IL2RB,1
lung carcinoma,BEVACIZUMAB,1,Terminated,VEGFA,1
lung carcinoma,BEVACIZUMAB,1,Withdrawn,VEGFA,1
lung carcinoma,BEVACIZUMAB,2,Not yet recruiting,VEGFA,1
lung carcinoma,BEXAROTENE,2,Unknown status,RXRA,1
lung carcinoma,BORTEZOMIB,1,Withdrawn,PSMB5,1
lung carcinoma,BORTEZOMIB,1,Terminated,PSMB5,1
lung carcinoma,BORTEZOMIB,1,Completed,PSMB5,1
lung carcinoma,BINIMETINIB,1,Recruiting,MAP2K2,1
lung carcinoma,BEXAROTENE,2,Unknown status,RXRG,1
lung carcinoma,BEXAROTENE,2,Unknown status,RXRB,1
lung carcinoma,BEXAROTENE,2,Completed,RXRG,1
lung carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,1
lung carcinoma,BEXAROTENE,2,Completed,RXRB,1
lung carcinoma,BEXAROTENE,2,Completed,RXRA,1
lung carcinoma,BEXAROTENE,1,Completed,RXRG,1
lung carcinoma,BEXAROTENE,1,Completed,RXRA,1
lung carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,1
lung carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
lung carcinoma,CI-1040,2,Completed,MAP2K1,1
lung carcinoma,CIXUTUMUMAB,2,Completed,IGF1R,1
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB1,1
lung carcinoma,DEXAMETHASONE,1,"Active, not recruiting",NR3C1,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4A,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB3,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2B,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2A,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB1,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
lung carcinoma,DIPHENHYDRAMINE,1,"Active, not recruiting",HRH1,1
lung carcinoma,DEXMEDETOMIDINE,4,Unknown status,ADRA2C,1
lung carcinoma,DEXMEDETOMIDINE,4,Unknown status,ADRA2B,1
lung carcinoma,DEXMEDETOMIDINE,4,Unknown status,ADRA2A,1
lung carcinoma,DEXMEDETOMIDINE,4,Completed,ADRA2C,1
lung carcinoma,DEXMEDETOMIDINE,4,Completed,ADRA2B,1
lung carcinoma,DEXMEDETOMIDINE,4,Completed,ADRA2A,1
lung carcinoma,DEXAMETHASONE,4,Unknown status,NR3C1,1
lung carcinoma,DEXAMETHASONE,4,Completed,NR3C1,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4B,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB6,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB8,1
lung carcinoma,DOCETAXEL,1,Terminated,TUBB2A,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB8,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB3,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2B,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2A,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB1,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB8,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB1,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB6,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4B,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4A,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB3,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2B,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2A,1
lung carcinoma,DEXAMETHASONE,3,Completed,NR3C1,1
lung carcinoma,DENOSUMAB,3,"Active, not recruiting",TNFSF11,1
lung carcinoma,CRIZOTINIB,1,"Active, not recruiting",ALK,1
lung carcinoma,DASATINIB,2,Terminated,YES1,1
lung carcinoma,DASATINIB,2,Completed,LCK,1
lung carcinoma,DASATINIB,2,Completed,KIT,1
lung carcinoma,DASATINIB,2,Completed,HCK,1
lung carcinoma,DASATINIB,2,Completed,FYN,1
lung carcinoma,DASATINIB,2,Completed,FRK,1
lung carcinoma,DASATINIB,2,Completed,FGR,1
lung carcinoma,DASATINIB,2,Completed,EPHA2,1
lung carcinoma,DASATINIB,2,Completed,BLK,1
lung carcinoma,DASATINIB,2,Completed,ABL1,1
lung carcinoma,DALTEPARIN SODIUM,4,Completed,SERPINC1,1
lung carcinoma,DALTEPARIN SODIUM,3,Completed,SERPINC1,1
lung carcinoma,DALOTUZUMAB,2,Withdrawn,IGF1R,1
lung carcinoma,DACOMITINIB,3,Completed,ERBB3,1
lung carcinoma,DABRAFENIB,2,Recruiting,BRAF,1
lung carcinoma,CRIZOTINIB,1,"Active, not recruiting",MET,1
lung carcinoma,DASATINIB,2,Completed,LYN,1
lung carcinoma,DASATINIB,2,Completed,PDGFRB,1
lung carcinoma,DASATINIB,2,Completed,SRC,1
lung carcinoma,DASATINIB,2,Terminated,HCK,1
lung carcinoma,DASATINIB,2,Terminated,SRMS,1
lung carcinoma,DASATINIB,2,Terminated,SRC,1
lung carcinoma,DASATINIB,2,Terminated,PDGFRB,1
lung carcinoma,DASATINIB,2,Terminated,LYN,1
lung carcinoma,DASATINIB,2,Terminated,LCK,1
lung carcinoma,DASATINIB,2,Terminated,KIT,1
lung carcinoma,DASATINIB,2,Terminated,FYN,1
lung carcinoma,DASATINIB,2,Completed,SRMS,1
lung carcinoma,DASATINIB,2,Terminated,FRK,1
lung carcinoma,DASATINIB,2,Terminated,FGR,1
lung carcinoma,DASATINIB,2,Terminated,EPHA2,1
lung carcinoma,DASATINIB,2,Terminated,BLK,1
lung carcinoma,DASATINIB,2,Terminated,ABL1,1
lung carcinoma,DASATINIB,2,Completed,YES1,1
lung carcinoma,KETAMINE,2,Completed,GRIN3A,1
lung carcinoma,LEPIRUDIN,1,Terminated,F2,1
lung carcinoma,ALDESLEUKIN,1,Terminated,IL2RA,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB6,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB4A,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB3,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB2B,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB2A,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB1,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB,1
lung carcinoma,PACLITAXEL,1,Terminated,TUBB6,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB8,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB6,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2B,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB1,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB4B,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB8,1
lung carcinoma,LIDOCAINE,1,Completed,SCN10A,1
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB3,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC1,1
lung carcinoma,PANITUMUMAB,2,"Active, not recruiting",EGFR,1
lung carcinoma,PALBOCICLIB,1,Recruiting,CDK6,1
lung carcinoma,PALBOCICLIB,1,Recruiting,CDK4,1
lung carcinoma,PALBOCICLIB,1,Recruiting,CCND1,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB6,1
lung carcinoma,OSIMERTINIB,3,Completed,ERBB4,1
lung carcinoma,OSIMERTINIB,3,Completed,ERBB3,1
lung carcinoma,OSIMERTINIB,3,Completed,ERBB2,1
lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB4,1
lung carcinoma,NIVOLUMAB,3,Terminated,PDCD1,1
lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B2,1
lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B1,1
lung carcinoma,NIRAPARIB,2,Recruiting,PARP3,1
lung carcinoma,NINTEDANIB,2,Recruiting,PDGFRB,1
lung carcinoma,NINTEDANIB,2,Recruiting,PDGFRA,1
lung carcinoma,NINTEDANIB,2,Recruiting,KDR,1
lung carcinoma,NINTEDANIB,2,Recruiting,FLT4,1
lung carcinoma,NINTEDANIB,2,Recruiting,FLT1,1
lung carcinoma,NINTEDANIB,2,Recruiting,FGFR4,1
lung carcinoma,NINTEDANIB,2,Recruiting,FGFR3,1
lung carcinoma,NINTEDANIB,2,Recruiting,FGFR2,1
lung carcinoma,NINTEDANIB,2,Recruiting,FGFR1,1
lung carcinoma,NIMOTUZUMAB,2,Recruiting,EGFR,1
lung carcinoma,NICOTINE,3,Terminated,CHRNB2,1
lung carcinoma,NIVOLUMAB,4,Recruiting,PDCD1,1
lung carcinoma,OBATOCLAX,1,Completed,BCL2A1,1
lung carcinoma,OBATOCLAX,1,Completed,BCL2L10,1
lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB3,1
lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB3,1
lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB2,1
lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB4,1
lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB3,1
lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB2,1
lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB4,1
lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB2,1
lung carcinoma,OBATOCLAX,1,Completed,MCL1,1
lung carcinoma,ORANTINIB,1,Unknown status,PDGFRB,1
lung carcinoma,ORANTINIB,1,Unknown status,KDR,1
lung carcinoma,ORANTINIB,1,Unknown status,FGFR4,1
lung carcinoma,ORANTINIB,1,Unknown status,FGFR3,1
lung carcinoma,ORANTINIB,1,Unknown status,FGFR2,1
lung carcinoma,ONARTUZUMAB,1,Withdrawn,MET,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC10,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC2,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC4,1
lung carcinoma,PEMETREXED,3,"Active, not recruiting",DHFR,1
lung carcinoma,PREDNISONE,2,Recruiting,NR3C1,1
lung carcinoma,PREDNISONE,1,Unknown status,NR3C1,1
lung carcinoma,PRAVASTATIN,3,Completed,HMGCR,1
lung carcinoma,PRALATREXATE,2,Completed,DHFR,1
lung carcinoma,PIOGLITAZONE,2,Unknown status,PPARG,1
lung carcinoma,PEMETREXED,3,Unknown status,TYMS,1
lung carcinoma,PEMETREXED,3,Unknown status,GART,1
lung carcinoma,PEMETREXED,3,Unknown status,DHFR,1
lung carcinoma,PEMETREXED,3,Recruiting,TYMS,1
lung carcinoma,PEMETREXED,3,Recruiting,GART,1
lung carcinoma,PEMETREXED,3,Recruiting,DHFR,1
lung carcinoma,PEMETREXED,3,Not yet recruiting,TYMS,1
lung carcinoma,PEMETREXED,3,Not yet recruiting,GART,1
lung carcinoma,PEMETREXED,3,Not yet recruiting,DHFR,1
lung carcinoma,PEMETREXED,3,"Active, not recruiting",TYMS,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA1,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA2,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA3,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRG1,1
lung carcinoma,PROPOFOL,4,Completed,GABRA2,1
lung carcinoma,PROPOFOL,4,Completed,GABRA1,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRQ,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRP,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRG3,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRG2,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRE,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA4,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRD,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRB3,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRB2,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRB1,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA6,1
lung carcinoma,PROPOFOL,2,Unknown status,GABRA5,1
lung carcinoma,PEMETREXED,3,"Active, not recruiting",GART,1
lung carcinoma,PEMETREXED,2,"Active, not recruiting",TYMS,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC5,1
lung carcinoma,PEMETREXED,2,"Active, not recruiting",GART,1
lung carcinoma,PAZOPANIB,2,Completed,LCK,1
lung carcinoma,PAZOPANIB,2,Completed,KIT,1
lung carcinoma,PAZOPANIB,2,Completed,KDR,1
lung carcinoma,PAZOPANIB,2,Completed,ITK,1
lung carcinoma,PAZOPANIB,2,Completed,FLT4,1
lung carcinoma,PAZOPANIB,2,Completed,FLT1,1
lung carcinoma,PAZOPANIB,2,Completed,FGFR3,1
lung carcinoma,PAZOPANIB,2,Completed,FGFR1,1
lung carcinoma,PAZOPANIB,2,Completed,CSF1R,1
lung carcinoma,PASIREOTIDE,2,"Active, not recruiting",SSTR5,1
lung carcinoma,PASIREOTIDE,2,"Active, not recruiting",SSTR3,1
lung carcinoma,PASIREOTIDE,2,"Active, not recruiting",SSTR2,1
lung carcinoma,PASIREOTIDE,2,"Active, not recruiting",SSTR1,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC9,1
lung carcinoma,PANOBINOSTAT,1,Withdrawn,HDAC7,1
lung carcinoma,PAZOPANIB,2,Completed,PDGFRA,1
lung carcinoma,PAZOPANIB,2,Completed,PDGFRB,1
lung carcinoma,PAZOPANIB,2,Terminated,CSF1R,1
lung carcinoma,PAZOPANIB,2,Terminated,PDGFRA,1
lung carcinoma,PEMETREXED,2,"Active, not recruiting",DHFR,1
lung carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
lung carcinoma,PEGVISOMANT,1,Terminated,GHR,1
lung carcinoma,PEGFILGRASTIM,3,Terminated,CSF3R,1
lung carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,1
lung carcinoma,PAZOPANIB,2,Terminated,PDGFRB,1
lung carcinoma,PAZOPANIB,2,Terminated,LCK,1
lung carcinoma,PAZOPANIB,2,Terminated,FGFR1,1
lung carcinoma,PAZOPANIB,2,Terminated,KIT,1
lung carcinoma,PAZOPANIB,2,Terminated,KDR,1
lung carcinoma,PAZOPANIB,2,Terminated,ITK,1
lung carcinoma,PAZOPANIB,2,Terminated,FLT4,1
lung carcinoma,PAZOPANIB,2,Terminated,FLT1,1
lung carcinoma,PAZOPANIB,2,Terminated,FGFR3,1
lung carcinoma,NICOTINE,3,Terminated,CHRNA4,1
lung carcinoma,MUPARFOSTAT,2,Completed,VEGFA,1
lung carcinoma,MUPARFOSTAT,2,Completed,HPSE,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA6,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB6,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB5,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB4,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB11,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB10,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFAF4,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFAF3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFAF2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFAF1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFAB1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA9,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA8,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB7,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB8,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFB9,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS7,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND1,1
lung carcinoma,METFORMIN,2,Terminated,GPD2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFV3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFV2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFV1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS8,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS6,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFC1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS5,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS4,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFS1,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFC2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA7,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA5,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA4L2,1
lung carcinoma,LIDOCAINE,4,Completed,SCN7A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN5A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN4A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN3A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN2A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN1A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN11A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN10A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN9A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN8A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN5A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN4A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN3A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN2A,1
lung carcinoma,LIDOCAINE,1,Completed,SCN1A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN8A,1
lung carcinoma,LIDOCAINE,4,Completed,SCN9A,1
lung carcinoma,METFORMIN,2,Recruiting,GPD2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA10,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA4,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA3,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA2,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA13,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA12,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA11,1
lung carcinoma,METFORMIN,2,Recruiting,NDUFA1,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND1,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND6,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND5,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND4L,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND4,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND3,1
lung carcinoma,METFORMIN,2,Recruiting,MT-ND2,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND2,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND4,1
lung carcinoma,MUPARFOSTAT,2,Completed,FGF2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS2,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRG2,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRG1,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRA5,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRA3,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRA2,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRA1,1
lung carcinoma,METHYLPREDNISOLONE,4,Completed,NR3C1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFV3,1
lung carcinoma,METFORMIN,2,Terminated,NDUFV2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFV1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS8,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS7,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS6,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS5,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS4,1
lung carcinoma,MIDAZOLAM,4,Completed,GABRG3,1
lung carcinoma,MK-2206,2,"Active, not recruiting",AKT1,1
lung carcinoma,MK-2206,2,"Active, not recruiting",AKT2,1
lung carcinoma,MOTESANIB,1,Terminated,PDGFRA,1
lung carcinoma,MUPARFOSTAT,2,Completed,FGF1,1
lung carcinoma,MOTESANIB,1,Unknown status,RET,1
lung carcinoma,MOTESANIB,1,Unknown status,PDGFRB,1
lung carcinoma,MOTESANIB,1,Unknown status,KDR,1
lung carcinoma,MOTESANIB,1,Unknown status,FLT1,1
lung carcinoma,MOTESANIB,1,Terminated,RET,1
lung carcinoma,MOTESANIB,1,Terminated,KIT,1
lung carcinoma,MK-2206,2,"Active, not recruiting",AKT3,1
lung carcinoma,MOTESANIB,1,Terminated,KDR,1
lung carcinoma,MOTESANIB,1,Terminated,FLT4,1
lung carcinoma,MOTESANIB,1,Terminated,FLT1,1
lung carcinoma,MOCETINOSTAT,1,Recruiting,HDAC3,1
lung carcinoma,MOCETINOSTAT,1,Recruiting,HDAC2,1
lung carcinoma,MOCETINOSTAT,1,Recruiting,HDAC11,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS3,1
lung carcinoma,METFORMIN,2,Terminated,NDUFS1,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND4L,1
lung carcinoma,METFORMIN,2,Terminated,NDUFC2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA8,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA7,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA6,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA5,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA4L2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA4,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA3,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA13,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA12,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA11,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA10,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA1,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND6,1
lung carcinoma,METFORMIN,2,Terminated,MT-ND5,1
lung carcinoma,METFORMIN,2,Terminated,NDUFA9,1
lung carcinoma,METFORMIN,2,Terminated,NDUFAB1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFAF1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB4,1
lung carcinoma,METFORMIN,2,Terminated,NDUFC1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB9,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB8,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB7,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB6,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB5,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB3,1
lung carcinoma,METFORMIN,2,Terminated,NDUFAF2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB2,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB11,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB10,1
lung carcinoma,METFORMIN,2,Terminated,NDUFB1,1
lung carcinoma,METFORMIN,2,Terminated,NDUFAF4,1
lung carcinoma,METFORMIN,2,Terminated,NDUFAF3,1
lung carcinoma,ALDESLEUKIN,2,Unknown status,IL2RA,1
lung carcinoma,AFLIBERCEPT,2,Completed,VEGFA,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,1
lung adenocarcinoma,CRIZOTINIB,2,Unknown status,ALK,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,1
large cell lung carcinoma,ERLOTINIB,3,Terminated,EGFR,1
large cell lung carcinoma,ERLOTINIB,2,Completed,EGFR,1
large cell lung carcinoma,DURVALUMAB,2,Recruiting,CD274,1
large cell lung carcinoma,CIXUTUMUMAB,2,Terminated,IGF1R,1
large cell lung carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,1
bronchogenic carcinoma,FLUTICASONE PROPIONATE,2,Completed,NR3C1,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB8,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB6,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB4B,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB4A,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB3,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB2B,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB2A,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,1
large cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4A,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2A,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB1,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB,1
large cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP1,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB8,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB6,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4B,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4A,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB3,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2B,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2A,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB1,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB8,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB6,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2B,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB3,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4A,1
lung adenocarcinoma,BEVACIZUMAB,2,Completed,VEGFA,1
lung adenocarcinoma,CRIZOTINIB,2,Terminated,ALK,1
lung adenocarcinoma,CIXUTUMUMAB,2,Terminated,IGF1R,1
lung adenocarcinoma,CETUXIMAB,1,Completed,EGFR,1
lung adenocarcinoma,BORTEZOMIB,2,Completed,PSMB5,1
lung adenocarcinoma,BEVACIZUMAB,3,Not yet recruiting,VEGFA,1
lung adenocarcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,1
lung adenocarcinoma,BEVACIZUMAB,1,Terminated,VEGFA,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4B,1
lung adenocarcinoma,AXL-1717,2,Completed,IGF1R,1
lung adenocarcinoma,APATINIB,2,Recruiting,KDR,1
lung adenocarcinoma,APATINIB,2,"Active, not recruiting",KDR,1
lung adenocarcinoma,APATINIB,1,Unknown status,KDR,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB8,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB6,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4B,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB3,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2B,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB8,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB6,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2B,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2A,1
large cell lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,1
large cell lung carcinoma,MK-2206,2,Completed,AKT3,1
large cell lung carcinoma,MK-2206,2,Completed,AKT2,1
large cell lung carcinoma,MK-2206,2,Completed,AKT1,1
large cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2A,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB1,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB8,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB6,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB3,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB1,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB1,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,1
adenosquamous lung carcinoma,MK-2206,2,Completed,AKT1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,1
adenosquamous lung carcinoma,MK-2206,2,Completed,AKT2,1
adenosquamous lung carcinoma,MK-2206,2,Completed,AKT3,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB4B,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB4A,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB3,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB2B,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB2A,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB1,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB8,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,1
adenosquamous lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB6,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,1
bronchoalveolar adenocarcinoma,MK-2206,2,Completed,AKT3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,1
bronchoalveolar adenocarcinoma,MK-2206,2,Completed,AKT2,1
bronchoalveolar adenocarcinoma,MK-2206,2,Completed,AKT1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",GPD2,1
bronchoalveolar adenocarcinoma,ERLOTINIB,2,Unknown status,EGFR,1
bronchoalveolar adenocarcinoma,BORTEZOMIB,2,Terminated,PSMB5,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB8,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB6,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB4B,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB4A,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB3,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB2B,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB2A,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,1
bronchoalveolar adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,1
lung adenocarcinoma,CRIZOTINIB,2,Terminated,MET,1
lung adenocarcinoma,CRIZOTINIB,2,Unknown status,MET,1
lung carcinoma,AFLIBERCEPT,2,Completed,PGF,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS5,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS3,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFC2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFC1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB9,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB8,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB7,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB6,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB5,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB4,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB3,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB11,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB10,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS4,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS6,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS7,1
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB4A,1
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB2A,1
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB,1
lung adenocarcinoma,OSIMERTINIB,2,Recruiting,ERBB4,1
lung adenocarcinoma,OSIMERTINIB,2,Recruiting,ERBB3,1
lung adenocarcinoma,OSIMERTINIB,2,Recruiting,ERBB2,1
lung adenocarcinoma,NIVOLUMAB,1,Withdrawn,PDCD1,1
lung adenocarcinoma,NIVOLUMAB,1,Terminated,PDCD1,1
lung adenocarcinoma,MK-2206,2,Completed,AKT3,1
lung adenocarcinoma,MK-2206,2,Completed,AKT2,1
lung adenocarcinoma,MK-2206,2,Completed,AKT1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFV3,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFV2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFV1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFS8,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFB1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFAF4,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFAF3,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFAF2,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND4L,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND4,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND3,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND2,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND1,1
lung adenocarcinoma,METFORMIN,2,Terminated,GPD2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFV3,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFV2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFV1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS8,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS7,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS5,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS4,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS3,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND5,1
lung adenocarcinoma,METFORMIN,2,Terminated,MT-ND6,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA5,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFAF1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFAB1,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA9,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA8,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA7,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA6,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA4L2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA10,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA4,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA3,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA2,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA13,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA12,1
lung adenocarcinoma,METFORMIN,2,Terminated,NDUFA11,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB1,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,1
lung adenocarcinoma,R428,2,Recruiting,AXL,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB2B,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB2A,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB1,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB8,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB6,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB4B,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB4A,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB3,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB2B,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB2A,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB1,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB,1
lung adenocarcinoma,TRAMETINIB,1,Recruiting,MAP2K2,1
lung adenocarcinoma,TRAMETINIB,1,Recruiting,MAP2K1,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB3,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB4A,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB4B,1
lung carcinoma,AFATINIB,2,Recruiting,ERBB4,1
lung carcinoma,AFATINIB,2,Withdrawn,ERBB4,1
lung carcinoma,AFATINIB,2,Withdrawn,ERBB2,1
lung carcinoma,AFATINIB,2,Withdrawn,EGFR,1
lung carcinoma,AFATINIB,2,Terminated,ERBB4,1
lung carcinoma,AFATINIB,2,Terminated,ERBB2,1
lung carcinoma,AFATINIB,2,Terminated,EGFR,1
lung carcinoma,AFATINIB,2,Recruiting,ERBB2,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB6,1
lung carcinoma,AFATINIB,2,Recruiting,EGFR,1
lung carcinoma,AFATINIB,2,Completed,ERBB4,1
lung carcinoma,AFATINIB,2,Completed,ERBB2,1
lung carcinoma,AFATINIB,2,Completed,EGFR,1
lung adenocarcinoma,VINTAFOLIDE,2,Completed,FOLR1,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB8,1
lung adenocarcinoma,SIROLIMUS,1,Recruiting,FKBP1A,1
lung adenocarcinoma,POZIOTINIB,2,Terminated,ERBB4,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB4B,1
lung adenocarcinoma,POZIOTINIB,2,Terminated,ERBB3,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB3,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB2B,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB2A,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB1,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB6,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB4A,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB4B,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB6,1
lung adenocarcinoma,PEMETREXED,2,Terminated,TYMS,1
lung adenocarcinoma,POZIOTINIB,2,Terminated,ERBB2,1
lung adenocarcinoma,POZIOTINIB,2,Terminated,EGFR,1
lung adenocarcinoma,POZIOTINIB,2,Completed,ERBB4,1
lung adenocarcinoma,POZIOTINIB,2,Completed,ERBB3,1
lung adenocarcinoma,POZIOTINIB,2,Completed,ERBB2,1
lung adenocarcinoma,POZIOTINIB,2,Completed,EGFR,1
lung adenocarcinoma,PEMETREXED,2,Terminated,GART,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB8,1
lung adenocarcinoma,PEMETREXED,2,Terminated,DHFR,1
lung adenocarcinoma,PEMETREXED,1,"Active, not recruiting",TYMS,1
lung adenocarcinoma,PEMETREXED,1,"Active, not recruiting",GART,1
lung adenocarcinoma,PEMETREXED,1,"Active, not recruiting",DHFR,1
lung adenocarcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,1
lung adenocarcinoma,PEMBROLIZUMAB,2,Not yet recruiting,PDCD1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFS1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFC2,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB2B,1
lung adenocarcinoma,GEFITINIB,3,Completed,EGFR,1
lung adenocarcinoma,GANETESPIB,3,Terminated,HSP90AB1,1
lung adenocarcinoma,GANETESPIB,3,Terminated,HSP90AA1,1
lung adenocarcinoma,FARLETUZUMAB,2,Completed,FOLR1,1
lung adenocarcinoma,ETOPOSIDE,3,Completed,TOP2B,1
lung adenocarcinoma,ETOPOSIDE,3,Completed,TOP2A,1
lung adenocarcinoma,ETOPOSIDE,1,Terminated,TOP2B,1
lung adenocarcinoma,ERLOTINIB,4,Unknown status,EGFR,1
lung adenocarcinoma,ERLOTINIB,1,Terminated,EGFR,1
lung adenocarcinoma,ERLOTINIB,1,Recruiting,EGFR,1
lung adenocarcinoma,DURVALUMAB,2,Recruiting,CD274,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB8,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB6,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB4B,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB4A,1
lung adenocarcinoma,LENVATINIB,2,Completed,FLT1,1
lung adenocarcinoma,LENVATINIB,2,Completed,FLT4,1
lung adenocarcinoma,LENVATINIB,2,Completed,KDR,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",GPD2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB3,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB2A,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB1,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB8,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB6,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB4B,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB4A,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB3,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB2B,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB2A,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB1,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB8,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB6,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB4A,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB3,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB1,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB1,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB2A,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB2B,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB2B,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB8,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB6,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB4B,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB4A,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB3,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB2A,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB3,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB1,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB8,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB6,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB4B,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB4A,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFC1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND3,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA7,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA5,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA4L2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA4,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA3,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA13,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA12,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA11,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA10,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND5,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND4L,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA8,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFA9,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFAB1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB3,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB9,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB8,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB7,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB5,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB4,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFAF1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB11,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB10,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFB1,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFAF4,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFAF3,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,NDUFAF2,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND4,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,MT-ND1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,1
lung adenocarcinoma,METFORMIN,2,Not yet recruiting,GPD2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,1
lung adenocarcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,1
lung carcinoma,PROPOFOL,4,Completed,GABRA3,1
lung carcinoma,PROPOFOL,4,Completed,GABRA4,1
lung carcinoma,PROPOFOL,4,Completed,GABRA5,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB1,1
non-small cell lung carcinoma,FLURBIPROFEN,4,Terminated,PTGS1,1
non-small cell lung carcinoma,FLUOROURACIL,2,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,FLUOROURACIL,1,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,FINASTERIDE,2,Terminated,SRD5A2,1
non-small cell lung carcinoma,FILGRASTIM,3,"Active, not recruiting",CSF3R,1
non-small cell lung carcinoma,FILGRASTIM,2,Completed,CSF3R,1
non-small cell lung carcinoma,FILGRASTIM,1,Withdrawn,CSF3R,1
non-small cell lung carcinoma,FIGITUMUMAB,3,Withdrawn,IGF1R,1
non-small cell lung carcinoma,FICLATUZUMAB,2,Terminated,HGF,1
non-small cell lung carcinoma,FEXOFENADINE,1,"Active, not recruiting",HRH1,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",PDGFRB,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",PDGFRA,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,FLURBIPROFEN,4,Terminated,PTGS2,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD3,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB3,1
non-small cell lung carcinoma,FULVESTRANT,2,Terminated,ESR2,1
non-small cell lung carcinoma,FULVESTRANT,2,Terminated,ESR1,1
non-small cell lung carcinoma,FULVESTRANT,1,Withdrawn,ESR2,1
non-small cell lung carcinoma,FULVESTRANT,1,Withdrawn,ESR1,1
non-small cell lung carcinoma,FULVESTRANT,1,Recruiting,ESR2,1
non-small cell lung carcinoma,FULVESTRANT,1,Recruiting,ESR1,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,KDR,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,FLT4,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,FLT1,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,KDR,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,FLT4,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,FLT1,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT3,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,KIT,1
non-small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2B,1
non-small cell lung carcinoma,ETIRINOTECAN PEGOL,2,Completed,TOP1,1
non-small cell lung carcinoma,ERLOTINIB,4,Unknown status,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,4,Suspended,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,4,Recruiting,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,3,Suspended,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,2,Enrolling by invitation,EGFR,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB8,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB6,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB4B,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB4A,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB3,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB2B,1
non-small cell lung carcinoma,ETOPOSIDE,1,Recruiting,TOP2B,1
non-small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,1
non-small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,1
non-small cell lung carcinoma,EXEMESTANE,1,"Active, not recruiting",CYP19A1,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,KDR,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT3,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,EZATIOSTAT,2,Terminated,GSTP1,1
non-small cell lung carcinoma,EXEMESTANE,2,Recruiting,CYP19A1,1
non-small cell lung carcinoma,EVEROLIMUS,2,Completed,FKBP1A,1
non-small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2A,1
non-small cell lung carcinoma,EVEROLIMUS,1,Unknown status,FKBP1A,1
non-small cell lung carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,1
non-small cell lung carcinoma,EVEROLIMUS,1,"Active, not recruiting",FKBP1A,1
non-small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2B,1
non-small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2A,1
non-small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2B,1
non-small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AA1,1
non-small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AB1,1
non-small cell lung carcinoma,GANETESPIB,2,Terminated,HSP90AA1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD2,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,1
non-small cell lung carcinoma,GANETESPIB,2,Terminated,HSP90AB1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD2,1
adenosquamous lung carcinoma,ERLOTINIB,2,Completed,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,Unknown status,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,Recruiting,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,GEFITINIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,GEFITINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R2,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R1,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CD,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CA,1
non-small cell lung carcinoma,GANETESPIB,3,Terminated,HSP90AB1,1
non-small cell lung carcinoma,GANETESPIB,3,Terminated,HSP90AA1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,1
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD2,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,PRIM2,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB2A,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB1,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,KDR,1
non-small cell lung carcinoma,DOXORUBICIN,1,Unknown status,TOP2A,1
non-small cell lung carcinoma,DROZITUMAB,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP8,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP7,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP13,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP1,1
non-small cell lung carcinoma,DOXORUBICIN,2,Not yet recruiting,TOP2A,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FGFR3,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,PDGFRA,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,DULANERMIN,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB2B,1
non-small cell lung carcinoma,DULANERMIN,2,Completed,TNFRSF10A,1
non-small cell lung carcinoma,DURVALUMAB,1,"Active, not recruiting",CD274,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB8,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC4,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC9,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC6,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC5,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC4,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC3,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC2,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC11,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC10,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC1,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC9,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC6,1
non-small cell lung carcinoma,ENZASTAURIN,1,Completed,PRKCB,1
non-small cell lung carcinoma,EPACADOSTAT,1,"Active, not recruiting",IDO1,1
non-small cell lung carcinoma,EPACADOSTAT,1,Recruiting,IDO1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB3,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB6,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB4A,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB3,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB2B,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB2A,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB2,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1A,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2C,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2B,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2A,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1D,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1B,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC5,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC3,1
non-small cell lung carcinoma,DURVALUMAB,1,Completed,CD274,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC2,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,LCK,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FRK,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FLT3,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR4,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR3,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR2,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,AURKA,1
non-small cell lung carcinoma,ENCORAFENIB,2,Withdrawn,BRAF,1
non-small cell lung carcinoma,EMIBETUZUMAB,2,Completed,MET,1
non-small cell lung carcinoma,EMIBETUZUMAB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,EGF816,2,Recruiting,EGFR,1
non-small cell lung carcinoma,EGF816,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,DURVALUMAB,4,n/a,CD274,1
non-small cell lung carcinoma,DURVALUMAB,3,Not yet recruiting,CD274,1
non-small cell lung carcinoma,DURVALUMAB,1,Suspended,CD274,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,LYN,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,PDGFRA,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,SRC,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC5,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC11,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC10,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC1,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC9,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC4,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,SRMS,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC3,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC11,1
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC1,1
non-small cell lung carcinoma,ENOXAPARIN SODIUM,3,Terminated,SERPINC1,1
non-small cell lung carcinoma,ENOXAPARIN SODIUM,3,Completed,SERPINC1,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,YES1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD4,1
lung carcinoma,PROPOFOL,4,Completed,GABRA6,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,KDR,1
non-small cell lung carcinoma,MOGAMULIZUMAB,1,Completed,CCR4,1
non-small cell lung carcinoma,MODAFINIL,4,Completed,SLC6A3,1
non-small cell lung carcinoma,MODAFINIL,2,Withdrawn,SLC6A3,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC8,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC3,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC2,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC11,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC1,1
non-small cell lung carcinoma,MM-121,1,Completed,ERBB3,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT3,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT2,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT1,1
non-small cell lung carcinoma,MIFEPRISTONE,2,Recruiting,PGR,1
non-small cell lung carcinoma,MIFEPRISTONE,2,Recruiting,NR3C1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRG3,1
non-small cell lung carcinoma,MOMELOTINIB,1,Terminated,JAK2,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,KIT,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,PDGFRA,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,FGF2,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,FGF1,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,TXNRD1,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM2B,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM2,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM1,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,RET,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,KIT,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,KDR,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,RET,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRG1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA5,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA2,1
non-small cell lung carcinoma,METHYLPREDNISOLONE,2,Recruiting,NR3C1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS8,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS7,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS6,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFC2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFC1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB9,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,FLT1,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,FLT4,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,MET,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA5,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA1,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,MST1R,1
non-small cell lung carcinoma,MGCD-265,2,Completed,TEK,1
non-small cell lung carcinoma,MGCD-265,2,Completed,MST1R,1
non-small cell lung carcinoma,MGCD-265,2,Completed,MET,1
non-small cell lung carcinoma,MGCD-265,2,Completed,KDR,1
non-small cell lung carcinoma,MGCD-265,2,Completed,FLT4,1
non-small cell lung carcinoma,MGCD-265,2,Completed,FLT1,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,HPSE,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,VEGFA,1
non-small cell lung carcinoma,NALOXEGOL,2,Recruiting,OPRM1,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,PDGFRA,1
non-small cell lung carcinoma,NIVOLUMAB,3,Not yet recruiting,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,2,Terminated,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,2,Suspended,PDCD1,1
non-small cell lung carcinoma,NITROGLYCERIN,2,Terminated,GUCY1B2,1
non-small cell lung carcinoma,NITROGLYCERIN,2,Terminated,GUCY1B1,1
non-small cell lung carcinoma,NIRAPARIB,1,Recruiting,PARP2,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,PDGFRB,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,KDR,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FLT4,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR4,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR3,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR1,1
non-small cell lung carcinoma,NIVOLUMAB,3,Terminated,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,4,n/a,PDCD1,1
non-small cell lung carcinoma,OLAPARIB,1,Completed,PARP2,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB2,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB2,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP1,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,OSIMERTINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,OLMUTINIB,2,Completed,EGFR,1
non-small cell lung carcinoma,OLARATUMAB,2,Completed,PDGFRA,1
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP3,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,PDGFRB,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,KDR,1
non-small cell lung carcinoma,NAPTUMOMAB ESTAFENATOX,1,Completed,TPBG,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FLT4,1
non-small cell lung carcinoma,NIMOTUZUMAB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Unknown status,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Terminated,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,4,n/a,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,3,Suspended,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2L2-PABPN1,1
non-small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2,1
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR1,1
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR4,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR3,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR1,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR4,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB8,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB7,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB6,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRG,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB8,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB6,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB4B,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB4A,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB3,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB2B,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB2A,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB1,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB,1
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB4A,1
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB2B,1
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB2A,1
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB1,1
non-small cell lung carcinoma,ITACITINIB,2,Withdrawn,JAK1,1
non-small cell lung carcinoma,ITACITINIB,2,Terminated,JAK1,1
non-small cell lung carcinoma,LAPATINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,LAPATINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,LAPATINIB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,FLT1,1
non-small cell lung carcinoma,LETROZOLE,1,Recruiting,CYP19A1,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,KDR,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,FLT4,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,FLT1,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,KDR,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,FLT4,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,KDR,1
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,CUL4A,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,RBX1,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,DDB1,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,CUL4A,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,CRBN,1
non-small cell lung carcinoma,ITACITINIB,2,Recruiting,JAK1,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRB,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,CSF1R,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRA,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Completed,TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Completed,TLR7,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,"Active, not recruiting",TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,"Active, not recruiting",TLR7,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Unknown status,TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Unknown status,TLR7,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Completed,TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Completed,TLR7,1
non-small cell lung carcinoma,GILTERITINIB,1,Terminated,FLT3,1
non-small cell lung carcinoma,GILTERITINIB,1,Terminated,AXL,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE2,1
non-small cell lung carcinoma,IBRUTINIB,2,Withdrawn,BTK,1
non-small cell lung carcinoma,IMETELSTAT,2,Completed,TERT,1
non-small cell lung carcinoma,IMGATUZUMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,IPILIMUMAB,1,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,IRINOTECAN,2,Terminated,TOP1,1
non-small cell lung carcinoma,IRINOTECAN,1,Unknown status,TOP1,1
non-small cell lung carcinoma,IPILIMUMAB,3,Withdrawn,CTLA4,1
non-small cell lung carcinoma,IPILIMUMAB,3,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,IPILIMUMAB,2,Suspended,CTLA4,1
non-small cell lung carcinoma,IPILIMUMAB,2,"Active, not recruiting",CTLA4,1
non-small cell lung carcinoma,IPH-2101,2,Recruiting,KIR2DL3,1
non-small cell lung carcinoma,IMGATUZUMAB,1,Withdrawn,FCGR3A,1
non-small cell lung carcinoma,IPH-2101,2,Recruiting,KIR2DL1,1
non-small cell lung carcinoma,IPH-2101,2,Not yet recruiting,KIR2DL3,1
non-small cell lung carcinoma,IPH-2101,2,Not yet recruiting,KIR2DL1,1
non-small cell lung carcinoma,IMIQUIMOD,2,Completed,TLR7,1
non-small cell lung carcinoma,IMGATUZUMAB,2,Completed,FCGR3A,1
non-small cell lung carcinoma,IMGATUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,LINAGLIPTIN,1,Recruiting,DPP4,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,FLT3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB5,1
non-small cell lung carcinoma,MATUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA13,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA12,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA11,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA10,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND6,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND4L,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,GPD2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA4L2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB11,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB10,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA6,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAB1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA9,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA8,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA7,1
non-small cell lung carcinoma,MERESTINIB,2,Recruiting,MET,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R5,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,FLT4,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R3,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CB,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",MTOR,1
non-small cell lung carcinoma,LY-3009120,1,Terminated,BRAF,1
non-small cell lung carcinoma,LY-2584702,1,Terminated,RPS6KB1,1
non-small cell lung carcinoma,LUMRETUZUMAB,1,Terminated,ERBB3,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,KDR,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR2,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR1,1
non-small cell lung carcinoma,LOPERAMIDE,3,Completed,OPRM1,1
non-small cell lung carcinoma,LONAFARNIB,3,Terminated,FNTB,1
non-small cell lung carcinoma,LONAFARNIB,3,Terminated,FNTA,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,PDGFRA,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,KDR,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CD,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CG,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R1,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,MTOR,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R2,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R1,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CG,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CD,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CB,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CA,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R3,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R2,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R1,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CG,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CD,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,MTOR,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R5,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R3,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB8,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB8,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB4B,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB4A,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB3,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB2B,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB2A,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB1,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA4A,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA3E,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA3C,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA1C,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA1B,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBA1A,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB8,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB6,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB6,1
lung carcinoma,VINORELBINE,1,Completed,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB6,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB3,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2B,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2A,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB1,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB4B,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB3,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB2B,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB1,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB8,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB6,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB2B,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB2A,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB1,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB4B,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB4A,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB3,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB2B,1
lung carcinoma,TIPIFARNIB,1,Completed,FNTB,1
lung carcinoma,THALIDOMIDE,3,Terminated,RBX1,1
lung carcinoma,THALIDOMIDE,3,Terminated,DDB1,1
lung carcinoma,THALIDOMIDE,3,Terminated,CUL4A,1
lung carcinoma,THALIDOMIDE,3,Terminated,CRBN,1
lung carcinoma,THALIDOMIDE,3,Completed,RBX1,1
lung carcinoma,THALIDOMIDE,3,Completed,DDB1,1
lung carcinoma,THALIDOMIDE,3,Completed,CUL4A,1
lung carcinoma,THALIDOMIDE,3,Completed,CRBN,1
lung carcinoma,THALIDOMIDE,2,Terminated,RBX1,1
lung carcinoma,THALIDOMIDE,2,Terminated,DDB1,1
lung carcinoma,THALIDOMIDE,2,Terminated,CUL4A,1
lung carcinoma,THALIDOMIDE,2,Terminated,CRBN,1
lung carcinoma,TEMSIROLIMUS,1,"Active, not recruiting",FKBP1A,1
lung carcinoma,TANESPIMYCIN,1,Completed,HSP90AB1,1
lung carcinoma,TOPOTECAN,2,Terminated,TOP1MT,1
lung carcinoma,TOPOTECAN,2,Unknown status,TOP1MT,1
lung carcinoma,TOPOTECAN,2,Withdrawn,TOP1MT,1
lung carcinoma,VARENICLINE,3,Recruiting,CHRNA4,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB2A,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB1,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB,1
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB6,1
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB3,1
lung carcinoma,VARENICLINE,3,Recruiting,CHRNB2,1
lung carcinoma,VALPROIC ACID,1,Completed,ALDH5A1,1
lung carcinoma,TOPOTECAN,3,"Active, not recruiting",TOP1MT,1
lung carcinoma,TRETINOIN,2,Completed,RARG,1
lung carcinoma,TRETINOIN,2,Completed,RARB,1
lung carcinoma,TRETINOIN,2,Completed,RARA,1
lung carcinoma,TREMELIMUMAB,2,"Active, not recruiting",CTLA4,1
lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K2,1
lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K1,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4A,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4B,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB6,1
non-small cell lung carcinoma,AFATINIB,1,Unknown status,ERBB2,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,1,Withdrawn,ERBB4,1
non-small cell lung carcinoma,AFATINIB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,AFATINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,AFLIBERCEPT,3,Completed,VEGFA,1
non-small cell lung carcinoma,AFLIBERCEPT,3,Completed,PGF,1
non-small cell lung carcinoma,AFLIBERCEPT,1,Completed,VEGFA,1
non-small cell lung carcinoma,AFLIBERCEPT,1,Completed,PGF,1
non-small cell lung carcinoma,AFATINIB,4,n/a,ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,n/a,ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,EGFR,1
non-small cell lung carcinoma,AFATINIB,4,Completed,ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,Completed,ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,Completed,EGFR,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,AFATINIB,1,Unknown status,ERBB4,1
non-small cell lung carcinoma,AFATINIB,1,Unknown status,EGFR,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB8,1
non-small cell lung carcinoma,AFATINIB,1,Recruiting,ERBB4,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4A,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB3,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2B,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2A,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB1,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB8,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB6,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB4B,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB4A,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB3,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB2B,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB2A,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB1,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4B,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB6,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB8,1
non-small cell lung carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK4,1
non-small cell lung carcinoma,AFATINIB,1,Recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,1,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,1,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,ACALABRUTINIB,2,Unknown status,BTK,1
non-small cell lung carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,ABEMACICLIB,1,Recruiting,CDK6,1
lung carcinoma,VOLOCIXIMAB,2,Unknown status,ITGA5,1
non-small cell lung carcinoma,ABEMACICLIB,1,Recruiting,CDK4,1
lung carcinoma,ZOLEDRONIC ACID,3,Recruiting,FDPS,1
lung carcinoma,ZOLEDRONIC ACID,2,Unknown status,FDPS,1
lung carcinoma,ZILEUTON,2,Completed,ALOX5,1
lung carcinoma,X-396,2,Recruiting,ALK,1
lung carcinoma,VOLOCIXIMAB,2,Unknown status,ITGB1,1
lung carcinoma,TANESPIMYCIN,1,Completed,HSP90AA1,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC9,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC8,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN5A,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA6,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA5,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA4,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA3,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA2,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRA1,1
lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K2,1
lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K1,1
lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K2,1
lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K1,1
lung carcinoma,SARGRAMOSTIM,1,Terminated,CSF2RA,1
lung carcinoma,RUXOLITINIB,1,Completed,JAK2,1
lung carcinoma,RUXOLITINIB,1,Completed,JAK1,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN9A,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN8A,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRB1,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRB2,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRB3,1
lung carcinoma,SEVOFLURANE,2,Unknown status,KCNK10,1
lung carcinoma,SIROLIMUS,1,Withdrawn,FKBP1A,1
lung carcinoma,SIMVASTATIN,2,Completed,HMGCR,1
lung carcinoma,SEVOFLURANE,2,Unknown status,KCNK9,1
lung carcinoma,SEVOFLURANE,2,Unknown status,KCNK3,1
lung carcinoma,SEVOFLURANE,2,Unknown status,KCNK2,1
lung carcinoma,SEVOFLURANE,2,Unknown status,KCNK18,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GLRA1,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRD,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRQ,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRP,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRG3,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRG2,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRG1,1
lung carcinoma,SEVOFLURANE,2,Unknown status,GABRE,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN7A,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN4A,1
lung carcinoma,SORAFENIB,1,Terminated,FLT1,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN3A,1
lung carcinoma,RETASPIMYCIN,2,Terminated,HSP90AB1,1
lung carcinoma,RETASPIMYCIN,2,Terminated,HSP90AA1,1
lung carcinoma,RETASPIMYCIN,1,Completed,HSP90AB1,1
lung carcinoma,RETASPIMYCIN,1,Completed,HSP90AA1,1
lung carcinoma,REMIFENTANIL,4,Unknown status,OPRM1,1
lung carcinoma,PROPOFOL,4,Completed,GABRQ,1
lung carcinoma,PROPOFOL,4,Completed,GABRP,1
lung carcinoma,PROPOFOL,4,Completed,GABRG3,1
lung carcinoma,PROPOFOL,4,Completed,GABRG2,1
lung carcinoma,PROPOFOL,4,Completed,GABRG1,1
lung carcinoma,PROPOFOL,4,Completed,GABRE,1
lung carcinoma,PROPOFOL,4,Completed,GABRD,1
lung carcinoma,PROPOFOL,4,Completed,GABRB3,1
lung carcinoma,PROPOFOL,4,Completed,GABRB2,1
lung carcinoma,PROPOFOL,4,Completed,GABRB1,1
lung carcinoma,RITUXIMAB,2,Completed,MS4A1,1
lung carcinoma,ROCURONIUM,2,Unknown status,CHRNA1,1
lung carcinoma,ROCURONIUM,2,Unknown status,CHRNB1,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC6,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN2A,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN1A,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN11A,1
lung carcinoma,ROPIVACAINE,4,Completed,SCN10A,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC9,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC8,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC4,1
lung carcinoma,ROCURONIUM,2,Unknown status,CHRND,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC3,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC2,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC11,1
lung carcinoma,ROMIDEPSIN,1,Completed,HDAC10,1
lung carcinoma,ROCURONIUM,2,Unknown status,CHRNG,1
lung carcinoma,ROCURONIUM,2,Unknown status,CHRNE,1
lung carcinoma,SORAFENIB,1,Terminated,BRAF,1
lung carcinoma,SORAFENIB,1,Terminated,FLT4,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC7,1
lung carcinoma,SUNITINIB,2,Terminated,CSF1R,1
lung carcinoma,SUNITINIB,2,Unknown status,PDGFRB,1
lung carcinoma,SUNITINIB,2,Unknown status,PDGFRA,1
lung carcinoma,SUNITINIB,2,Unknown status,KIT,1
lung carcinoma,SUNITINIB,2,Unknown status,KDR,1
lung carcinoma,SUNITINIB,2,Unknown status,FLT4,1
lung carcinoma,SUNITINIB,2,Unknown status,FLT3,1
lung carcinoma,SUNITINIB,2,Unknown status,FLT1,1
lung carcinoma,SUNITINIB,2,Unknown status,CSF1R,1
lung carcinoma,SUNITINIB,2,Terminated,RET,1
lung carcinoma,SUNITINIB,2,Terminated,PDGFRB,1
lung carcinoma,SUNITINIB,2,Terminated,PDGFRA,1
lung carcinoma,SUNITINIB,2,Terminated,KIT,1
lung carcinoma,SUNITINIB,2,Terminated,KDR,1
lung carcinoma,SUNITINIB,2,Terminated,FLT4,1
lung carcinoma,SUNITINIB,2,Terminated,FLT3,1
lung carcinoma,SUNITINIB,2,Unknown status,RET,1
lung carcinoma,SUNITINIB,2,Withdrawn,CSF1R,1
lung carcinoma,SUNITINIB,2,Withdrawn,FLT1,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC10,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC6,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC5,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC4,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC3,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC2,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC11,1
lung carcinoma,TACEDINALINE,3,Completed,HDAC1,1
lung carcinoma,SUNITINIB,2,Withdrawn,FLT3,1
lung carcinoma,SUNITINIB,2,Withdrawn,RET,1
lung carcinoma,SUNITINIB,2,Withdrawn,PDGFRB,1
lung carcinoma,SUNITINIB,2,Withdrawn,PDGFRA,1
lung carcinoma,SUNITINIB,2,Withdrawn,KIT,1
lung carcinoma,SUNITINIB,2,Withdrawn,KDR,1
lung carcinoma,SUNITINIB,2,Withdrawn,FLT4,1
lung carcinoma,SUNITINIB,2,Terminated,FLT1,1
lung carcinoma,SORAFENIB,2,Withdrawn,RET,1
lung carcinoma,SORAFENIB,1,Terminated,RAF1,1
lung carcinoma,SORAFENIB,2,Withdrawn,RAF1,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",PDGFRB,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",KIT,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",KDR,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",FLT4,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",FLT3,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",FLT1,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",BRAF,1
lung carcinoma,SORAFENIB,1,Withdrawn,RET,1
lung carcinoma,SORAFENIB,1,Withdrawn,KIT,1
lung carcinoma,SORAFENIB,1,Withdrawn,KDR,1
lung carcinoma,SORAFENIB,1,Withdrawn,FLT4,1
lung carcinoma,SORAFENIB,1,Withdrawn,FLT3,1
lung carcinoma,SORAFENIB,1,Withdrawn,FLT1,1
lung carcinoma,SORAFENIB,1,Withdrawn,BRAF,1
lung carcinoma,SORAFENIB,1,Terminated,RET,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",RAF1,1
lung carcinoma,SORAFENIB,2,"Active, not recruiting",RET,1
lung carcinoma,SORAFENIB,2,Unknown status,BRAF,1
lung carcinoma,SORAFENIB,2,Withdrawn,BRAF,1
lung carcinoma,SORAFENIB,2,Withdrawn,PDGFRB,1
lung carcinoma,SORAFENIB,2,Withdrawn,KIT,1
lung carcinoma,SORAFENIB,2,Withdrawn,KDR,1
lung carcinoma,SORAFENIB,2,Withdrawn,FLT4,1
lung carcinoma,SORAFENIB,2,Withdrawn,FLT3,1
lung carcinoma,SORAFENIB,2,Withdrawn,FLT1,1
lung carcinoma,SORAFENIB,2,Unknown status,RET,1
lung carcinoma,SORAFENIB,2,Unknown status,FLT1,1
lung carcinoma,SORAFENIB,2,Unknown status,RAF1,1
lung carcinoma,SORAFENIB,2,Unknown status,PDGFRB,1
lung carcinoma,SORAFENIB,2,Unknown status,KIT,1
lung carcinoma,SORAFENIB,2,Unknown status,KDR,1
lung carcinoma,SORAFENIB,2,Unknown status,FLT4,1
lung carcinoma,SORAFENIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,AGATOLIMOD,3,Terminated,TLR9,1
non-small cell lung carcinoma,ALCLOMETASONE DIPROPIONATE,2,Completed,NR3C1,1
non-small cell lung carcinoma,ALDOXORUBICIN,2,Not yet recruiting,TOP2A,1
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGB3,1
non-small cell lung carcinoma,CRIZOTINIB,2,Completed,MET,1
non-small cell lung carcinoma,CRIZOTINIB,2,Completed,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,1,Terminated,MET,1
non-small cell lung carcinoma,CRIZOTINIB,1,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,COBIMETINIB,2,Recruiting,MAP2K2,1
non-small cell lung carcinoma,COBIMETINIB,2,Recruiting,MAP2K1,1
non-small cell lung carcinoma,COBIMETINIB,1,Recruiting,MAP2K2,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,PDGFRB,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,KIT,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,KDR,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,FLT3,1
non-small cell lung carcinoma,CIXUTUMUMAB,2,Terminated,IGF1R,1
non-small cell lung carcinoma,CIXUTUMUMAB,1,Completed,IGF1R,1
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGB5,1
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGB3,1
non-small cell lung carcinoma,CRIZOTINIB,2,Withdrawn,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,2,Withdrawn,MET,1
non-small cell lung carcinoma,CRIZOTINIB,3,Completed,ALK,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC10,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC7,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC6,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC5,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC3,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC2,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC11,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC1,1
non-small cell lung carcinoma,CRIZOTINIB,3,Completed,MET,1
non-small cell lung carcinoma,CUDC-101,1,Completed,ERBB2,1
non-small cell lung carcinoma,CUDC-101,1,Completed,EGFR,1
non-small cell lung carcinoma,CRIZOTINIB,4,n/a,MET,1
non-small cell lung carcinoma,CRIZOTINIB,4,n/a,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,4,Recruiting,MET,1
non-small cell lung carcinoma,CRIZOTINIB,4,Recruiting,ALK,1
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGB5,1
non-small cell lung carcinoma,CI-1040,2,Completed,MAP2K2,1
non-small cell lung carcinoma,DABRAFENIB,2,Withdrawn,BRAF,1
non-small cell lung carcinoma,CI-1040,2,Completed,MAP2K1,1
non-small cell lung carcinoma,CAPECITABINE,1,Terminated,TYMS,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,ERBB4,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,ERBB2,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,CANAKINUMAB,1,Recruiting,IL1B,1
non-small cell lung carcinoma,CALCITRIOL,1,Completed,VDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,Suspended,MET,1
non-small cell lung carcinoma,CABOZANTINIB,2,Suspended,KDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,Completed,MET,1
non-small cell lung carcinoma,CABOZANTINIB,2,Completed,KDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,CABOZANTINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,CABOZANTINIB,1,Completed,KDR,1
non-small cell lung carcinoma,BUPROPION,1,Withdrawn,SLC6A2,1
non-small cell lung carcinoma,BUPIVACAINE,3,Recruiting,SCN4A,1
non-small cell lung carcinoma,CAPECITABINE,3,Terminated,TYMS,1
non-small cell lung carcinoma,CAPMATINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,CAPMATINIB,2,Withdrawn,MET,1
non-small cell lung carcinoma,CELECOXIB,3,Unknown status,PTGS2,1
non-small cell lung carcinoma,CETUXIMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,CETUXIMAB,2,Unknown status,EGFR,1
non-small cell lung carcinoma,CETUXIMAB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,CETUXIMAB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,CERITINIB,4,n/a,ALK,1
non-small cell lung carcinoma,CERITINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,CELECOXIB,3,Suspended,PTGS2,1
non-small cell lung carcinoma,CAROTUXIMAB,1,"Active, not recruiting",ENG,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,KIT,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,CAROTUXIMAB,1,Recruiting,ENG,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC9,1
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB3,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R3,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,YES1,1
non-small cell lung carcinoma,DECITABINE,1,Recruiting,DNMT3A,1
non-small cell lung carcinoma,DECITABINE,1,Recruiting,DNMT1,1
non-small cell lung carcinoma,DASATINIB,2,Completed,YES1,1
non-small cell lung carcinoma,DASATINIB,2,Completed,SRMS,1
non-small cell lung carcinoma,DASATINIB,2,Completed,SRC,1
non-small cell lung carcinoma,DASATINIB,2,Completed,PDGFRB,1
non-small cell lung carcinoma,DASATINIB,2,Completed,LYN,1
non-small cell lung carcinoma,DASATINIB,2,Completed,LCK,1
non-small cell lung carcinoma,DASATINIB,2,Completed,KIT,1
non-small cell lung carcinoma,DASATINIB,2,Completed,HCK,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FYN,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FRK,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FGR,1
non-small cell lung carcinoma,DASATINIB,2,Completed,EPHA2,1
non-small cell lung carcinoma,DASATINIB,2,Completed,BLK,1
non-small cell lung carcinoma,DECITABINE,2,"Active, not recruiting",DNMT1,1
non-small cell lung carcinoma,DECITABINE,2,"Active, not recruiting",DNMT3A,1
non-small cell lung carcinoma,DEFACTINIB,2,Completed,PTK2,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A1,1
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB1,1
non-small cell lung carcinoma,DISULFIRAM,2,Completed,ALDH2,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A4,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A3,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A2,1
non-small cell lung carcinoma,DEXAMETHASONE,4,Terminated,NR3C1,1
non-small cell lung carcinoma,DEFACTINIB,2,Completed,PTK2B,1
non-small cell lung carcinoma,DEXAMETHASONE,3,"Active, not recruiting",NR3C1,1
non-small cell lung carcinoma,DEXAMETHASONE,1,Completed,NR3C1,1
non-small cell lung carcinoma,DESLORATADINE,2,Recruiting,HRH1,1
non-small cell lung carcinoma,DENOSUMAB,2,Completed,TNFSF11,1
non-small cell lung carcinoma,DEMCIZUMAB,2,Completed,DLL4,1
non-small cell lung carcinoma,DEMCIZUMAB,1,Completed,DLL4,1
non-small cell lung carcinoma,DASATINIB,2,Completed,ABL1,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,SRMS,1
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,LYN,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",ABL1,1
non-small cell lung carcinoma,DARATUMUMAB,1,"Active, not recruiting",CD38,1
non-small cell lung carcinoma,DALOTUZUMAB,2,Completed,IGF1R,1
non-small cell lung carcinoma,DALOTUZUMAB,1,Completed,IGF1R,1
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB3,1
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB4,1
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB3,1
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,EGFR,1
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB3,1
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,EGFR,1
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,ERBB4,1
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,ERBB2,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FYN,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",HCK,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,ABL1,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,LCK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,KIT,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,HCK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,FYN,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,FGR,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,EPHA2,1
non-small cell lung carcinoma,DASATINIB,1,Completed,YES1,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",LYN,1
non-small cell lung carcinoma,DASATINIB,1,Completed,SRC,1
non-small cell lung carcinoma,DASATINIB,1,Completed,LCK,1
non-small cell lung carcinoma,DASATINIB,1,Completed,EPHA2,1
non-small cell lung carcinoma,DASATINIB,1,Completed,BLK,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",YES1,1
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",PDGFRB,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R5,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R2,1
non-small cell lung carcinoma,ALECTINIB,1,"Active, not recruiting",RET,1
non-small cell lung carcinoma,APRICOXIB,1,Completed,PTGS2,1
non-small cell lung carcinoma,AXITINIB,1,Completed,KDR,1
non-small cell lung carcinoma,AXITINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,AXITINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,AVELUMAB,2,Recruiting,CD274,1
non-small cell lung carcinoma,AVELUMAB,2,Not yet recruiting,CD274,1
non-small cell lung carcinoma,AVELUMAB,1,Not yet recruiting,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,4,"Active, not recruiting",CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Terminated,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Completed,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Withdrawn,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Terminated,CD274,1
non-small cell lung carcinoma,ASPIRIN,3,Withdrawn,PTGS2,1
non-small cell lung carcinoma,ASPIRIN,3,Withdrawn,PTGS1,1
non-small cell lung carcinoma,ASPIRIN,2,Unknown status,PTGS2,1
non-small cell lung carcinoma,ASPIRIN,2,Unknown status,PTGS1,1
non-small cell lung carcinoma,AXITINIB,1,Recruiting,FLT4,1
non-small cell lung carcinoma,AXL-1717,1,Completed,IGF1R,1
non-small cell lung carcinoma,AXL-1717,2,Completed,IGF1R,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR1,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR1,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR4,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR3,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR2,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR1,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR4,1
non-small cell lung carcinoma,AZD-2014,2,Terminated,MTOR,1
non-small cell lung carcinoma,AZACITIDINE,1,Completed,DNMT3A,1
non-small cell lung carcinoma,AZD-2014,2,"Active, not recruiting",MTOR,1
non-small cell lung carcinoma,AZACITIDINE,2,Recruiting,DNMT3A,1
non-small cell lung carcinoma,AZACITIDINE,2,Recruiting,DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,2,"Active, not recruiting",DNMT3A,1
non-small cell lung carcinoma,AZACITIDINE,2,"Active, not recruiting",DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,1,Unknown status,DNMT3A,1
non-small cell lung carcinoma,ARMODAFINIL,1,Withdrawn,SLC6A3,1
non-small cell lung carcinoma,APREPITANT,3,Unknown status,TACR1,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR3,1
non-small cell lung carcinoma,APREPITANT,2,Recruiting,TACR1,1
non-small cell lung carcinoma,ANETUMAB RAVTANSINE,1,Recruiting,MSLN,1
non-small cell lung carcinoma,ANAMORELIN,2,Completed,GHSR,1
non-small cell lung carcinoma,AMG-888,1,Completed,ERBB3,1
non-small cell lung carcinoma,ALECTINIB,4,n/a,RET,1
non-small cell lung carcinoma,ALECTINIB,4,n/a,ALK,1
non-small cell lung carcinoma,ALECTINIB,3,Not yet recruiting,RET,1
non-small cell lung carcinoma,ALECTINIB,3,Not yet recruiting,ALK,1
non-small cell lung carcinoma,ALECTINIB,3,Completed,RET,1
non-small cell lung carcinoma,ALECTINIB,3,Completed,ALK,1
non-small cell lung carcinoma,ALECTINIB,2,Not yet recruiting,RET,1
non-small cell lung carcinoma,ALECTINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,ALECTINIB,2,"Active, not recruiting",RET,1
non-small cell lung carcinoma,ALECTINIB,2,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,ALECTINIB,1,Completed,RET,1
non-small cell lung carcinoma,ALECTINIB,1,Completed,ALK,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,KIT,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,PDGFRB,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,FLT4,1
non-small cell lung carcinoma,APATINIB,4,Not yet recruiting,KDR,1
non-small cell lung carcinoma,APATINIB,2,Completed,KDR,1
non-small cell lung carcinoma,APATINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,PDGFRB,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,KIT,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,KDR,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,PDGFRB,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,KIT,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,KDR,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR2,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR4,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R1,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,ABL1,1
non-small cell lung carcinoma,BRIGATINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,BRIGATINIB,4,n/a,ALK,1
non-small cell lung carcinoma,BRIGATINIB,3,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,BRIGATINIB,3,Not yet recruiting,ALK,1
non-small cell lung carcinoma,BRIGATINIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,BRIGATINIB,3,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,BRIGATINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,BRIGATINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,BRIGATINIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,BRIGATINIB,2,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,BRIGATINIB,1,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,BRIGATINIB,1,Not yet recruiting,ALK,1
non-small cell lung carcinoma,BPI-9016,1,Unknown status,MET,1
non-small cell lung carcinoma,BPI-9016,1,Unknown status,AXL,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,LYN,1
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CA,1
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CG,1
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R3,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R1,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CG,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CD,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CB,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CA,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R5,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R3,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CD,1
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R5,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CB,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CA,1
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R5,1
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R3,1
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R2,1
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CD,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,HCK,1
non-small cell lung carcinoma,BORTEZOMIB,2,"Active, not recruiting",PSMB5,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT1,1
non-small cell lung carcinoma,BORTEZOMIB,1,Unknown status,PSMB5,1
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC2,1
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC10,1
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC1,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC8,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC7,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC3,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC10,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC1,1
non-small cell lung carcinoma,AZD-6738,2,Recruiting,ATR,1
non-small cell lung carcinoma,AZD-6738,2,Not yet recruiting,ATR,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT3,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT2,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT1,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT3,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT2,1
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC3,1
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC4,1
non-small cell lung carcinoma,BERZOSERTIB,1,Recruiting,ATR,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRB,1
non-small cell lung carcinoma,BORTEZOMIB,1,Completed,PSMB5,1
non-small cell lung carcinoma,BINIMETINIB,1,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,BINIMETINIB,1,Recruiting,MAP2K2,1
non-small cell lung carcinoma,BINIMETINIB,1,Recruiting,MAP2K1,1
non-small cell lung carcinoma,BI-2536,2,Completed,PLK1,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRG,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRA,1
non-small cell lung carcinoma,BEVACIZUMAB,1,Not yet recruiting,VEGFA,1
non-small cell lung carcinoma,BEXAROTENE,1,Terminated,RXRB,1
non-small cell lung carcinoma,BEXAROTENE,1,Terminated,RXRA,1
non-small cell lung carcinoma,BEVACIZUMAB,4,n/a,VEGFA,1
non-small cell lung carcinoma,BEVACIZUMAB,3,Unknown status,VEGFA,1
non-small cell lung carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
non-small cell lung carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB8,1
